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Abstract
Peptoids are peptidomimetic polymers, which have attracted much attention over the past
two decades. They have similar building blocks to peptides, and the similarity makes the backbone
of peptoids hydrophilic and biocompatible.1 Two types of peptoid polymers are under development.
One is sequence-defined peptoids, which exhibit excellent bioactivities.2 Another one is
polypeptoids. The good biocompatibility and highly tunable side chain substituents allow
polypeptoids to be used broadly in future biomedical applications.
Varying polymer architectures, including linear polymers, cyclic polymers, comb-like
polymers, and dendrimers can provide distinctive properties to the polymers. Cyclic polymers
employ a cyclic architecture and lack chain ends, so their diffusion behaviors, aggregation
behaviors, thermal transition behaviors, and crystallization behaviors are very different from the
linear analogs. Facile synthetic approaches are required to expand the application of cyclic
polymers into a broader scope. In chapter 1, the history of polypeptoids, the synthesis of cyclic
polymers, the development of functional polypeptoids, and the cutting-edge biomedical research
of polypeptoids were reviewed.
In chapter 2, we reported our most recent work of the polymerization reaction of cyclic
polypeptoids using a bicyclic amidine initiator. The study was described from the aspects of
molecular weight control, identification of the polymerization, kinetics of the polymerization, and
polymer

architecture.

Zwitterionic

ring-opening

polymerization

of

N-substituted

N-

carboxyanhydrides (R-NCA) mediated by the bicyclic amidine has been developed and welldefined cyclic polypeptoids can be synthesized.
Pursuit of varying polymer architectures never ends because unique properties can be
possibly discovered with the latest developed architecture. Besides cyclic polymers, linear
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bottlebrush polymers also attracted much attention due to their distinctive features. In chapter 3,
we took one step forward and synthesized the cyclic bottlebrush polypeptoids. We then conducted
a systematic study on the characterization of the cyclic bottlebrush polypeptoids and on the
solution aggregation behaviors of zwitterionic cyclic polypeptoids with and without long side
chains. It was revealed that zwitterionic cyclic polypeptoids tend to form clusters due to dipoledipole interaction in methanol and even the long side chains cannot prevent this process.
Another important direction of polypeptoid research, the biomedical application, was
assessed in chapter 4. Redox-responsive micelles based on amphiphilic diblock copolypeptoids
were prepared, and the solution stability, the morphology in dry state, the redox-responsive
behaviors, drug release in vitro, and cell viability and cell inhibition activity of the micelles were
completely studied.

ix

Chapter 1. Introduction to the Polypeptoid Research
1.1 Polypeptoids
1.1.1 History and unique properties
Polypeptoids, also known as poly(N-substituted glycine)s, are structural mimics of
polypeptides. Despite the backbone similarity to polypeptides, polypeptoids have the substituents
connected to the amide nitrogen instead of the backbone carbon, which leads to their achirality
and lack of hydrogen bonding along the backbone. As a result, polypeptoids feature enhanced
proteolytic stability and thermoprocessability relative to polypeptides. On the contrary to
polypeptides whose conformations in solution are determined by their backbone chirality and
hydrogen bonding, conformations of polypeptoids only depend on their side chains. With different
side chains, polypeptoids can form random coils, polyproline I helix,3-8 or nanosheets in solution.911

Due to the distinctive properties polypeptoids are good candidates as a class of peptidomimetic

materials in the areas of pharmaceutical therapy and biomedical applications (e.g. antimicrobial
coatings, biosensor fabrication, etc.). Developed as a derivative of polypeptides, the progressed
synthetic approaches enabled the production of diverse polypeptoids with much potential to be
used predominantly for the future biomedical application.

In the 1980s, under the revolution of genetic engineering, small biotechnology companies
were trying to develop more efficient technologies to facilitate the drug discovery process so that
they could expand into the pharmaceutical industry. Peptoids were therefore first produced by a
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start-up company- Protos in place of peptides and nucleic acid oligomers due to enhanced
pharmacokinetics. Since then sequence-defined peptoids were studied for drug discovery or as
binding agents in the pharmaceutical industry.12
There is not a distinct boundary between oligomeric peptoids and polypeptoids. Usually
peptoids with specific sequences and less than 50 units are considered oligomeric peptoids, and
peptoids whose backbone structures contain more than 20 repeating units are considered
polypeptoids. The most simple polypeptoid- polysarcosine or poly(N-methyl glycine) (PNMG)
was synthesized several decades ago through ring-opening polymerization (ROP) of N-methyl Ncarboxyanhydride (Me-NCA) monomers with amine initiators,13 but it was not unambiguously
distinguished from polypeptides by then. The broad and systematic studies of polypeptoids started
from recent years when the synthesis of the N-substituted N-carboxyanhydride (R-NCA)
monomers with versatile substituents and the synthesis of corresponding polypeptoids had been
developed. Up to date well-defined polypeptoids with controlled chain-length, narrow molecular
weight distribution (PDI), and various side chains can be readily synthesized.
The backbone of polypeptoids consisting of tertiary amide bonds is very hydrophilic and
has strong dipole-dipole interaction. In order to obtain polypeptoids with wide range of tunability,
one has to tailor their side chain substituents. It was found that the thermal and crystallization
behaviors14-17 and other physicochemical properties18 of polypeptoids are strongly dependent on
the substituents.
Luxenhofer et al. found that the hydrophilic and lipophilic balance (HLB) of polypeptoids
in solution can be tuned by adjusting both the chain length of backbones and side chain
substituents.19 Zuckermann et al. demonstrated that the persistence length of charged polypeptoids
depends on the specific charge position along the backbone.20 Solubility of polypeptoids in water
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can be tailored by side chains too. When the side chains are short alkyl chains (methyl or ethyl
groups) or hydrophilic side chains (methoxy or ethoxy groups) polypeptoids are water-soluble.
When the side chains are alkyl chains with four or more carbons polypeptoids become hydrophobic.
Polypeptoids also exhibit thermally induced phase transition behaviors in water when the side
chains are propyl groups or allyl groups or when they are random copolymers with ethyl and butyl
groups as side chains.1, 21
1.2 Synthesis of Linear Polypeptoids
1.2.1 Submonomer method
Scheme 1.1. Submonomer method.

Naturally occurring peptides are able to fold into higher ordered structures and thereby
exhibit varying biological activities. In order to mimic the folding behaviors of peptides, the effect
of the specific sequences of peptoids must be investigated. Therefore, the precise control over
sequences of peptoids is important.22 Submonomer solid phase synthesis is a broadly used method
to synthesize polypeptoids or more accurately sequence-defined peptoids.23 It is a polymerization
that includes two synthetic steps: acylation of the secondary amine in the presence of an acylating
agent- carbodiimide and displacement of the halogen with a primary amine. By repeating this
synthetic cycle primary amines with varying substituents can be incorporated onto the peptoid
chains, resulting in the precise control over the sequence of N-substituted polyglycine segments
(Scheme 1.1). The method is cost-effective because the amines used in this synthesis are not
necessary to be protected and most primary amines with varying substituents are commercially
available. As it has already been adapted to robotic synthesizer, it is an attractive method to obtain
-3-

sequence-defined peptoids. The main drawback of this method is the limit of the peptoid chain
length and the amount of materials that can be produced. So far the longest reported peptoids
synthesized by this method only have 50 repeating units.2 For scientists who need peptoids to be
high molecular weight polymers with better thermal and mechanical properties, submonomer
method is apparently not an appropriate approach.
1.2.2 Polymerizations of NCA monomers
Polypeptides can be synthesized via the ring opening polymerization of five-membered
ring N-carboxyanhydride (NCA) monomers.24 In order to synthesize polypeptoids in such way
polymer chemists developed N-substituted N-carboxyanhydride (R-NCA) monomers. .
Scheme 1.2. Synthesis of R-NCA monomers.

The synthesis of R-NCA usually follows a three-step synthetic pathway (Scheme 1.2). The
commercially available primary amine is first reacted with glyoxylic acid or bromoacetate and
then acidified with hydrochloric acid to yield the N-substituted glycine HCl salt.25 The HCl salt of
the amino acid is then protected by di-tert-butyl dicarbonate (Boc2O) or benzyl chloroformate.26
The alkoxy-protected precursor or benzyl formate-protected precursor is finally cyclized with the
presence of phosphorus chloride (PCl3) and purified by sublimation.27 The cycling agent can also
be phosphorus tribromide (PBr3), thionyl chloride (SOCl2), acyl chloride (AcCl)21 or acetic
anhydride,26 as long as they can convert the carboxylic acid into a better electrophile (e.g. acyl
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chloride, acyl bromide or anhydride), which facilitates the ring closure through nucleophilic attack
from the carbonyl of the carbamate group. So far R-NCA monomers with alkyl, alkene, alkyne, or
benzyl substituents, or short polyethylene glycol chains as substituents have been synthesized
(Scheme 1.3).7, 28, 29 The progress of NCA synthesis facilitates comprehensive investigations of
polypeptoids’ properties and the development of polypeptoids as novel materials for various
applications. One drawback of R-NCA monomers is their high sensitivity towards moisture, which
means that R-NCA must be stored and polymerized under a moisture-free condition. The
emergence of thio-analogs of R-NCA, N-thiocarboxyanhydrides (R-NTAs), is a potential
resolution to the limit of polypeptoid synthesis. Due to the substitution of the oxygen with sulfur,
the 5-carbonyl becomes less electrophilic, leading to higher stability against moisture (Scheme
1.4). The synthesis and polymerization of N-methyl-NTA and N-butyl-NTA have been reported.
30, 31

Scheme 1.3. R-NCA monomers with varying side chain substituents.

Scheme 1.4. R-NTA monomer.
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As early as the 1920s, it was demonstrated by Fuchs and Wessely that primary amines can
attack the 5 carbonyl of the NCA monomers to trigger the ring-opening polymerizations (ROP).13
This polymerization was well-developed to study N-substitute effect pertaining to polypeptide
synthesis, and N-methyl NCA (Me-NCA) was one of the mostly used model. 32, 33 As the synthetic
routes towards R-NCA monomers became more developed, Me-NCA was then identified as the
simplest R-NCA, and the traditional amine-initiated polymerization of NCA, which was used to
produce polypeptides, readily became accessible to the synthesis of polypeptoids.26 Up to date,
this is the most popular approach to produce linear polypeptoids with varying side chains,
compositions, and properties (Scheme 1.5).
Scheme 1.5. ROP of R-NCA monomers using primary amine as an initiator

As the initiation of ROP of R-NCA monomers was triggered by nucleophilic attack on the
5 carbonyl, other nucleophilic initiators should also be able to initiate the polymerization. Although
primary alcohols have weaker nucleophilicity than primary amines, they were recently
demonstrated by Zhang et al. that can initiate the ROP of R-NCA monomers in a controlled manner.
34

The polymerization of R-NCA monomers occurs by using an electron-rich primary alcohol

initiator with the presence of catalytic amount of 1,1,3,3-tetramethylguanidine (TMG). TMG was
used as a promoter that can activate the alcohol initiator via hydrogen bonding interaction (Scheme
1.6). This approach enables a good control over molecular weight (MW) and molecular weight
-6-

distribution (PDI) of the resulting polypeptoids. This study indicates that weak nucleophiles can
be used to synthesize polypeptoids with the presence of activators, and more combinations of
organic nucleophiles and activators are awaiting discovery. New synthetic approaches of
polypeptoids employing this combination are possible to provide better control over number
average molecular weight (Mn) and higher efficiency, and the resulting polypeptoids with diverse
functional end-groups can be expanded into broader applications.
Scheme 1.6. TMG-Promoted ROP of R-NCA with alcohol initiators. (Reprinted with permission
from reference34, copyright (2016) American Chemical Society).

1.3 Cyclic Polypeptoids
1.3.1 Properties and development of cyclic polymers
Cyclic polymers adopt a closed ring structure and do not contain end-group species, which
plays an important role in determining the properties of linear polymers. The unique cyclic
architecture imparts many distinctive properties to cyclic polymers. It was found that cyclic
polymers have lower intrinsic viscosity,35, 36 higher glass transition and melting temperatures,14, 37
faster crystallization rates,38,

39

and wider LCST (lower critical solution temperature) phase

transition windows relative to the linear counterparts.40 Recent studies revealed the influences of
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the unique architecture on the aggregation behaviors and mechanical properties of cyclic polymer
materials. It was found that both the core and shell of micelles formed by amphiphilic cyclic
polymers are more densely packed than those of their linear analogs,41 and thereby micelles
consisting of cyclic polymers possess enhanced stability against salt and thermal changes.42 Cyclic
polystryrene-b-polyisoprene was found to adopt micellar microstructures in their crystalline
domains, whereas the linear analogs form 2-d hexagonal packing.43 Cyclic polystyrene-bpolybutadiene tends to have smaller domain spacing than linear counterparts,44 which is in favor
of block copolymer lithography by minimizing the characteristic dimensions of nanopatterns.45 It
was reported by Tew et al. that the gel network formed by crosslinked cyclic polyoctene exhibits
improved mechanical properties than their linear analogs attributed to the extra mesh space created
by the cyclic architecture within the gel network.46 Regarding biomedical applications, it was
found that the ring architecture of cyclic polymers facilitates higher gene transfection efficiency
than their linear counterparts do presumably due to their more compact conformations and stronger
interactions with DNA molecules.

47

In the same study, cyclic polymers also exhibit advantages

against branched polymers. It was revealed that cyclic polymers with much smaller molecular
weight feature comparable gene transfection efficiency to the branched polymers with higher
molecular weight. Given that smaller molecular weight polymers usually lead to less cytotoxicity,
cyclic polymers have shown promising potentials for biomedical applications.
1.3.2 Synthesis of cyclic polymers
1.3.2.1 Ring-closure method
To date, several synthetic approaches have been developed to synthesize cyclic polymers.
Ring-closure method which cyclizes the linear polymer precursors by using cyclizing agents is a
traditional method to synthesize cyclic polymers. For instance, cyclic polyisoprene-b-polystyrene-
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b-polyisoprene triblock copolymers were obtained by end-to-end cyclization of the linear
precursors using a cyclizing agent- 1, 6-diaminohexane at 100 oC. 48 Synthesis of cyclic polymers
through the ring-closure method became popular when copper-mediated cycloaddition was
employed as the ring-closure chemistry for unimolecular polymer chains having alkyne and azido
groups at chain ends. So far cyclic polymers including polystyrene,

49

polyacrylamide,40,

50

polylactones,51 and poly(ethylene imine) have been produced by this method.47 However, intermolecular end-to-end reaction is always a competing process during cyclization. Many factors (e.g.
chain length, chain flexibility, and solution concentration) must be optimized to minimize the
competing process, which limits the application of the ring-closure method.52
1.3.2.2 Ring-expansion polymerization
Ring-expansion polymerization (REP) is another pathway to obtain cyclic polymers. By
using cyclic tin initiators, lactone monomers can be inserted into the cyclic rings through the SnO or Sn-S bond to form cyclic polyesters. The polymerization requires extra steps to remove the
metallic initiators if the resulting cyclic polyesters are targeted for biological purposes.53 An
analog of REP is the ring-expansion metathesis polymerization (REMP), which is initiated by
cyclic ruthenium initiators and then proceeding via insertion of the cyclooctene monomers or their
derivatives into the double bonds of the cyclic initiating moieties. Cyclic polyoctenamers and their
derivatives have been successfully prepared by this method.36, 54 Based on the traditional synthetic
pathways, recently developed synthetic strategies allow for the synthesis of more complicated
cyclic polymers.55-58
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1.3.2.3 Zwitterionic ring-opening polymerization (ZROP)
Zwitterionic ring opening polymerization (ZROP) is another facile synthetic approach that
can produce cyclic polymers by overcoming some of the drawbacks of previously discussed
approaches. ZROP entails the formation of a zwitterionic propagating intermediate where the two
chain ends are oppositely charged and interact strongly with one another by electrostatic
interaction.59 The zwitterionic intermediate can either react with monomers (by a chain growth
mechanism) or with each other (by a step growth mechanism) to elongate the chain or undergo
intramolecular chain transfer to yield a mixture of linear and cyclic polymers (via backbiting
mechanism). Intramolecular chain transfer that occurs exclusively in an end-to-end fashion will
produce macrocyclic polymers cleanly. While the end-to-end macrocyclization is entropically
unfavored, high molecular weight cyclic polymers can be cleanly produced by the ZROP method
when the interactions between the oppositely charged chain ends of the zwitterionic propagating
intermediates overcome the entropic penalties.59 A distinct advantage of the ZROP method is that
the polymerization can be conducted in moderate to high monomer concentration, enabling
efficient access to cyclic polymers. This is in contrast to the ring-closure method of linear polymer
precursors that typically requires high dilution conditions.
ZROP has recently emerged as a promising strategy to produce high molecular weight
cyclic polymers with diverse backbone structures (e.g., polyester60-63 and polyamide).64 For
example, it was recently reported that isothiourea can mediate the ZROP of lactide to produce
cyclic polylactides with relatively high cyclic polymer contents in spite of somewhat slow
polymerization rates.65 B(C6F5)3 was used as the electrophilic initiator to mediate the ZROP of
glycidyl monomers to yield cyclic polyethers.66 Several recent studies have shown that Nheterocyclic carbenes (NHCs) can initiate and mediate the ZROPs of strained cyclic monomers
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(e.g., lactides, caprolactone, and carbosiloxane) to produce high molecular weight macrocyclic
polylactides, polylactones, and polycarbosiloxanes with moderate to high efficiency.60-62, 67 Cyclic
gradient polyesters can be obtained by NHC-mediated ZROP of ε-caprolactone (CL) and δvalerolactone (VL) in a one-pot reaction.68 We have recently demonstrated that a variety of cyclic
poly(N-substituted glycine) (a.k.a. polypeptoids) with varying N-substituents can be obtained by
NHC-mediated ZROP of the corresponding R-NCA monomers.1, 64, 69, 70 The reactions were shown
to occur in a controlled manner, producing cyclic polypeptoids with well-defined structure,
molecular weight and narrow molecular weight distribution. This is in contrast to early studies on
pyridine/tertiary amine/solvent initiated or thermally initiated ZROPs of Me-NCA which only
produce low molecular weight cyclic poly(N-methyl glycine) (a.k.a. polysarcosine).71-74
1.3.3 Analysis of cyclic polymers
End-group analysis using the combination of 1H NMR (proton nuclear magnetic resonance)
and MALDI-TOF MS (matrix assisted laser desorption ionization-time of flight mass spectrometry)
is a common method to detect the cyclic architecture when the end-group and the polymer
backbone structures are known. This method is an indirect measurement, and a complementary
measurement must be performed to support the architectural confirmation. Size exclusion
chromatography (SEC) is widely employed to analyze cyclic polymers. The intrinsic viscosity,
radius of gyration, and hydrodynamic volume of cyclic polymers can be measured by a SEC-light
scattering-viscometer-DRI (SEC-LS-VIS-DRI) online system. The measurement of linear
counterparts as a control group is necessary to suggest the cyclic architecture. This method usually
demands large amounts of samples and complicated sample preparations with very limited
analytical outcomes besides the architectural information. In contrast, microscopic analysis is able
to directly measure the size and the architecture of cyclic polymers in both dry state or solution
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phase. It was previously demonstrated that the atomic force microscopy (AFM) can be used to
reveal the cyclic backbone architecture.75-80 When it comes to other physical parameters of cyclic
polymers (e.g. radius of gyration, persistence length, Kuhn length, etc.) small angle x-ray
scattering (SAXS) or small-angle neutron scattering (SANS) are mostly used. Up to date some
good examples have shown us that scattering analysis of cyclic polymers is of importance for
better understanding the properties of cyclic polymers. Quantitatively analysis of a worm-like
chain (c-ATPC) revealed that the helix pitch per residue and the Kuhn segment length of the
specific rigid ring are independent of the solvent, which is opposite to the corresponding linear
analog, indicating a different local conformation from linear polymers.81 The absorption of cyclic
PEG onto silica particles studied by small angle neutron scattering (SANS) has shown that cyclic
PEG has higher absorption on silica nanoparticles than the linear analog does, but the thickness of
the c-PEG layer decreases as the molecular weight increases, which is very different from the
linear PEG.82 In addition, scattering functions based on various cyclic polymer models have been
built, enabling the essential basis for further investigation of cyclic polymers into a broader scope.
1.4 Functional Polypeptoids
In the past few years, more and more functional polypeptoids became available thanks to
the progress of synthetic strategies. Functional polypeptoids with alkene and alkyne side chains
can be readily synthesized, allowing for post-modifications of polypeptoids for various purposes.
Alkene reactions including ozonolysis, alkene metathesis, and thiol-ene click chemistry were
carried out to convert the double bond of poly glutamate to other side chains like alcohol, aldehyde,
carboxylic acid et al.83 It is possible to functionalize poly(N-allyl glycine) (PNAG) via the same
method. Schlaad et al. demonstrated that post-modification of PNAGs via thiol-ene click
chemistry is feasible to connect either 1-thio-β-D-glucose tetraacetate or 1-thio-β-D-glucose onto
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the side chains of polypeptoids to improve the bio-activity of polypeptoids.84 Poly(N-propargyl
glycine) (PNPgG) is the most popular model polypeptoid bearing alkyne groups on the side chains.
The same research group also demonstrated that several reactions can be performed with the alkyne
groups of PNPgG, including thiol-yne radical addition, deprotonation and nucleophilic addition of
ethylene oxide, thermally induced cross-linking, and the copper-mediated cycloaddition. 85
As the progress has been made to produce polypeptoids with well-defined Mn (number
average molecular weight) and PDI, polypeptoid nano-rods can be fabricated by seeding primary
amines onto various substrates. Garno et al. fabricated nano-rods comprising PNAG on a silica
surface by in-situ ROP using (3-aminopropyl)triethoxysilane initiators.86 Adopting this idea, MeNCA was surface-polymerized on a silica surface pretreated by either photolithography or
microcontact method to prepare well-defined surface patterns of polypeptoids in a micro-scale.87
The precise control over the micro-scale or even nano-scale lithography allows for the evaluation
of directional growth of polymers. More importantly it sets a platform for future fabrication of
bioelectronics and biosensors made of polypeptoids.
Thermoresponsive hydrogels consisting of A-B-C triblock copolypeptoids, (poly(N-allyl
glycine)-b-poly(N-methyl glycine)-b-poly(N-decyl glycine) (PNAG-b-PNMG-b-PNDG), were
prepared by Zhang et al. In this material methyl glycine (Me) is used as the hydrophilic segment
and decyl glycine (De) is used as the hydrophobic segment. Allyl glycine (Al) is also incorporated
because of its thermoresponsive properties. The A-B-C triblock copolymers self-assemble into
micelles in solution at room temperature, and undergo sol-gel transition within a wide range of
gelation temperatures (26 oC to 41 oC) with various polymer compositions. 29 The sol-gel transition
behavior is attributed to the thermo-responsive behaviors of the Al segments. When the
temperature is increased above the LCST of Al, the original dissolved Al segments become
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insoluble in aqueous solution and collapse together to form hydrophobic domains in addition to
the original De hydrophobic domains, resulting in the formation of 3-dimentional networks. The
resulting gels with a wide range of storage modulus (G’) and Young’s modulus (E) can be tailored
by controlling the polymer composition and the solution concentration. The hydrogels are
injectable and can be potentially used to encapsulate enzymes without affecting their bioactivities.
This is a model platform for the development of drug delivery, tissue engineering and protein
storage.
1.5 Cytotoxicity Assessment of Polypeptoids
Peptoids were initially produced as pharmaceutical agents, and it was demonstrated that
they have good biocompatibility and protease stability relative to peptides. Since then polymer
chemists devoted much effort to expanding the applications of peptoid materials including the
optimization of the monomer synthesis and polymerization, post-modification, and the assessment
of the physicochemical properties of the polypeptoids. Till now polypeptoids with various side
chains, compositions and structures, and physical properties have been produced under controlled
manners. Based on the accomplishment of the first-stage study, now scientists can take a step
forward to apply polypeptoids as biomaterials for biomedical applications. The bridge that
connects the two stages is the evaluation of biological properties of polypeptoids.
A cytotoxicity study is the first step to evaluate the biocompatibility of a biomaterial. Zhang
et al. investigated the cytotoxicity of cyclic poly [(N-ethyl glycine)-r-(N-butyl glycine)]s [P(NEGr-NBG)]s using the CellTiter Blue cell viability assay. The cyclic polymers were incubated with
Human embryonic lung fibroblasts (HEL229in PBS buffers for 24 h at varying concentrations
from 0.039 to 5.0 mg·mL−1. After 1 day incubation the cell viability was still above 80 % which
is on par with the results tested with low molecular polyethylene glycol (PEG).1 Luxenhofer et al.
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evaluated cytotoxicity of polypeptoids by incubating PNMG50 homo-polypeptoid and block
copolypeptoids including poly(N-methyl glycine)50-b-poly(N-propyl glycine)43 [PNMG50-bPNPG43], poly(N-methyl glycine)50-b-poly(N-pentyl glycine)10 [PNMG50-b-PNPenG10] et al. with
Human liver carcinoma cells (HepG2) for 24 h in medium. The upper limits of polypeptoid
concentrations lied in 2-10 mg/mL depending on the solubility of the polymer in medium and the
results indicated minimum cytotoxicity of polypeptoids to HepG2 cells.19 Ling et al. carried out
the biocompatibility evaluation of a series of thermoresponsive PNMG-r-PNBGs with HepG2
cells for 48 h in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer. All samples
exhibited minimum toxicity to HepG2 cells when the concentration was as low as 0.1 mg·mL-1.
By further increasing the concentrations of the samples to 3 mg/mL, the random copolymer whose
LCST is way above 37 oC still showed minimum cytotoxicity as homo-PNMG did, but for those
random copolymers whose LCSTs are close or lower than 37 oC they slightly precipitated out and
caused inhibition to the growth of HepG2 cells.30, 88 So far, homo-PNMG and random or block
copolypeptoids exhibit good biocompatibility with cells, but for thermoresponsive polypeptoids
the effect of temperature on their cytotoxicity remains to be investigated.
1.6 Drug Delivery Using Polymeric Micelles
1.6.1 History and development of drug delivery systems based on amphiphilic copolymers
When amphiphilic block copolymers are dissolved in an aqueous solution, the hydrophobic
segments are surrounded by water molecules, which is called hydrophobic hydration. When the
concentration of the polymers reaches the critical micelle concentration (CMC), hydrophobic
segments start to get dehydrated and form hydrophobic zones. This entropy-driven process is
called micellization. The study of polymeric micelles can date back to the 1960s when the solution
properties of micelles comprising Pluronic Polyols were investigated.89 Early studies of polymeric
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micelles were mainly conducted in organic solvents.90-93 Until the 1990s people started thinking
about utilizing the cargo structure of polymeric micelles for small molecule transportations in
biomedical applications. Yokoyama et al. first developed adriamycin-conjugated polymeric
micelles comprising polyethylene glycol- polypropylene glycol- polyethylene glycol (PEO-PPOPEO) triblock copolymers in aqueous solution and conducted systematic biological studies of this
drug delivery system. Their results implied that admin-conjugated micelles have good anti-tumor
activity.94 In their subsequent study the pharmacokinetics of the system was assessed, and it was
found that the system has elongated circulation time in vivo.95 Since then polymeric micelles have
been widely investigated as nanocarriers for drug delivery applications. The early studies provided
adequate evidence that polymeric micelles are capable of enhancing the water solubility of
hydrophobic drugs, protecting drugs against degrading enzymes, overcoming multi-drug
resistance (MRD),

96, 97

improving accumulation of drugs selectively at the diseased sites, and

increasing circulation time of drugs in human body.98-100
Conventional polymeric micelles formed by self-assembly of amphiphilic block
copolymers via hydrophobic interactions may spontaneously dissociate upon dilution, resulting in
pre-leakage during drug delivery. Allen et al. found that conventional micelles composed of poly
(ethylene glycol)-b-poly (caprolactone) are able to maintain their stability in vivo even below their
CMC presumably due to their relatively stable semicrystalline core, and thereby the pre-leakage
issue can be avoided, but the method of preparing such semi-crystalline micellar core is only
limited to certain materials.101 To enhance the in vivo stability of the polymeric micelles,
crosslinking of the micellar core or shell has been widely adopted. Liu et al. prepared several
crosslinked nanostructures formed by amphiphilic block copolymers mainly in organic solvents.
Based on their previous studies, they reported a newer work in 1997 that poly(2-cinnamoylethyl
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methacrylate)-b-poly(acrylic acid) (PCEMA-b-PAA) was used to construct water-soluble and
core-crosslinked micelles (CCLMs) which were shown to be able to maintain the well-defined
nanostructures permanently even in dilute conditions.102 Meanwhile, shell-crosslinked micelles
(SCM) based on polystyrene-b-poly(4-vinyl pyridine) were also developed by Wooley et al. in
order to resemble the properties and behaviors of dendrimers in solution.103 In their subsequent
study, SCMs made of poly(caprolactone)-b-poly(acrylic acid) were prepared via crosslinking
between the diamine crosslinkers and the carboxylic acid side chains. Based on the resulting SCM
they further hydrolyzed the core of poly(acrylic acid) to obtain hollow spherical nano-cages, which
can be potentially used as nanocarriers with high loadings.104 Despite of avoiding the stability and
pre-leakage issues of conventional polymeric micelles, the permanently crosslinked micelles,
which cannot be disintegrated, may be difficult to remove through renal clearance.105 In order to
achieve controlled drug release, stimuli-responsive CCLMs, which can maintain their structures
upon dilution and undergo dissociation in response to environmental cues, have been investigated
in the last decade.106, 107
1.6.2 State of the art of stimuli-responsive core-crosslinked micelles
Nanocarriers based on polymeric micelles that are responsive to light,108-111
temperature,112-114 enzymes, pH, and a reductive environment have been developed for controlled
drug delivery applications. Among all these triggers, construction of crosslinked micelles
responsive to pH or a redox environment has become widely employed. Studies have shown that
tumor tissues have reduced pH values and a different redox environment from normal tissues.115,
116

Controlled drug release is more likely to be accomplished if the pathophysiological

characteristics of tumors can be utilized. Preparation of pH responsive micelles usually requires
ionic pendants on the backbone of amphiphilic copolymers. When the pH transforms from the
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basic to the acidic, the ionic pendants get protonated and the solubility of the polymer segments
gets inverted, therefore leading to the rupture of micellar structures and drug release.117 When it
comes to neutral amphiphilic copolymers, another strategy that incorporates redox-responsive
covalent bonds into the micellar system is usually adopted. Kataoka et al. is one of the groups that
developed reduction-responsive CCLMs at the very beginning by aerial oxidation of the thiolfunctionalized poly (ethylene glycol)-b-poly (lysine) copolymers of the micelles. The reductionresponsive behavior of CCLMs was demonstrated by the release of pre-loaded oligo-nucleotides
from the CCLMs under a reductive environment.118 Since then redox-responsive polymeric
micelles have been judiciously designed by incorporating redox responsive units (e.g., disulfide,
diselenide119, thio-ether120 and acrylboronic ester121) either into the polymer backbones, 122, 123 side
chains124, 125 or cross-linkers.126-128 These micelles were shown to respond to oxidants (e.g., H2O2)
or reductants (e.g., glutathione (GSH)) that are naturally present in the cellular environment by
undergoing morphological changes.
1.6.3 The development of polymers used to construct micelles
Early attempts at the formation of polymeric micelles used various polymers for
amphiphilic block segments including polystyrene,129 polyisoprene,130 polyethylene oxide, and
polydimethylsiloxane.131 Among these materials, Pluronic, a triblock amphiphilic copolymer
(PEO-PPO-PEO), was the most popular one to be used to construct micelles due to its commercial
accessibility.132 In the 1990s, several groups contributed significant effort into comprehensive
studies on the properties of micelles formed by Pluronic.133 Phase behaviors, rheology, and
thermodynamics of Pluronic micelles in aqueous solutions were systematically studied, and the
results of these studies boosted the fast progress of varying polymeric micelles for biomedical
applications in the next 20 years.134-136 The design of polymeric micelles later on required that the
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building blocks of the nanocarriers used in vivo are minimally cytotoxic and backbone degradable,
allowing for systematic clearance of the materials. The hydrophilic block of Pluronic- polyethylene
glycol (PEG) was therefore extensively used with other biodegradable blocks to construct redox
responsive micelles due to its commercial accessibility and good biocompatibility (e.g.
polypeptide-b-poly(ethylene glycol) (PEG),126 poly(ε-caprolactone)-b-PEG,128 polylactide-bPEG,137 and poly(tyrosine(alkynyl)-OCA)-b-PEG127,

138

). So far PEG is the most widely

investigated polymer for various drug delivery systems including several PEGylated micellar or
liposomal formulations in advanced clinical studies,139-142 but studies have shown that PEG can
trigger complement activation,143,

144

and PEGylated liposomes can be cleared rapidly upon

repeated injections.145-148 There is a clear and continued need to develop and investigate new
micellar materials for drug delivery applications.
1.6.4 Aggregation of polypeptoids in solutions
In order to use polypeptoids for drug delivery, the first step is to understand the relationship
between their structures and their aggregation behaviors in solution. Cyclic and linear PNMG100b-PNDG10 amphiphilic block copolypeptoids synthesized by sequential polymerizations were
found to self-assemble into spherical micelles in MeOH at 1mg·mL-1 concentration, and after a
few days both of the self-assemblies transformed into micro-scale cylindrical micelles. This
morphological transition is tentatively attributed to the gradual crystallization of the decyl
segments. Recently, Zuckermann et al. synthesized monodisperse amphiphilic diblock
copolypeptoids (poly(N-decyl glycine)-b-poly(N-2-(2-(2-methoxyethoxy) ethoxy) ethyl glycine) )
with the same hydrophilic and hydrophobic chain lengths. It was found that hollow and
multiwalled crystalline nanotubes with diameters ranging from 4.3 to 9.0 nm can be accessed by
the self-assembly of the copolypeptoids with varying chain lengths.149 Another systematic study
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into the aggregation behaviors of amphiphilic copolypeptoids in aqueous solution was reported. A
series of amphiphilic copolypeptoids (poly(N-methyl glycine)-b-poly(N-propyl/butyl/pentyl
glycine)s) with slight differences in their compositions was synthesized. The effects of
hydrophilic/lipophilic balance (HLB) on CMC and aggregation behaviors of these copolypeptoids
were attempted to be investigated, but several conclusions made in this study remain ambiguous.
First, in this study the trend of CMC in micromolar concentration is not proportional to the increase
of HLB. Second, the suggestions that higher HLB results in smaller size aggregates and lower
HLB results in larger aggregates are not persuasive because the numbers representing the sizes of
larger aggregates were obtained from broad size distributions without PDI reported and the
example used as smaller aggregates has even bigger aggregates than those so-called larger
aggregates. Third, their suggestion that when the hydrophilic fraction= 50 % they may have wormlike micelles composed of polypeptoids formed in aqueous solution was proposed based on only
the multi-modal size distributions of polypeptoid aggregates. In order to support this assumption,
they did not show any microscopic results besides citing references from other groups focusing on
the effect of HLB on the morphology. More work must be completed to efficiently and completely
understand the relationship between chemical structures and aggregation behaviors, and micelles
comprising polypeptoids with various desired properties can then be easily fabricated.
1.6.5 Polypeptoid used as drug delivery systems
Some recent studies focusing on the construction of drug delivery systems comprising
biocompatible polymers have incorporated polypeptoids, more accurately poly(N-methyl glycine)block-polypeptide

copolymers.

Block

copolymers,

polysarcosine-b-polylysine-ε-N-

benzyloxycarbonyl acid benzylester, were synthesized through sequential ring opening
polymerizations of NCA monomers. The resulting polymers were able to self-assemble into
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micelles that are 28 nm in diameter without drug and 33 nm in diameter with hydrophobic drugs
loaded.150 Block copolymers of poly(N-methyl glycine)-b-polyglutamic acid (OBn) were
synthesized via a similar pathway by using a mannose-terminated primary amine initiator, and
then self-assembled into micelles covered by mannose with diameters around 70 nm. The resulting
micelles exhibited improved cell uptake when they were incubated with DC 2.4 cells and in bone
marrow-derived dendritic cells (BMDCs) which bear mannose-receptors. Targeted drug delivery
was already demonstrated possible by using polypeptoid-based micelles.151 The application of
polypeptoids for gene transfer was also demonstrated by the same group. Poly(N-methyl glycine)b-polylysine was synthesized and then complexed with DNA. The obtained polyplexes were then
incubated with HEK 293T cells and showed up to 50% transfection efficiency.152 Stimuliresponsive polypeptoid-based micelles were prepared by using a Boc-protected cystamine as the
initiator. The disulfide-linked block copolymers were synthesized by the polymerization of one
block using the initiator and then the deprotection of the amino group of the cystamine moieties to
initiate the polymerization of another block of polymers. The amphiphilic and redox-responsive
copolypeptoids can self-assemble into micelles and undergo degradation with the presence of
reducing agents like glutathione.153
1.6.6 Pharmacokinetics
Block copolymers with PNMG as the hydrophilic segment and poly (lactic acid) (PLLA)
as the hydrophobic segment were used to prepare micelles called Lactosome. The
pharmacokinetics of Lactosome were studied in vivo. The results revealed that Lactosome causes
an accelerated blood clearance (ABC) phenomenon in tumor-bearing mice suggested by the
production of anti-lactosome IgM and IgG3 related to B-lymphocyte cells. The ABC phenomenon
results in the trap of Lactosome in the liver upon multiple dosages. The enzyme-linked
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immunosorbent assay (ELISA) study indicated that the epitope moiety is due to PNMG although
it was developed intentionally to replace PEG.154 This ABC issue of Lactosome can be avoided by
using (poly(N-methyl glycine)s23)3-b-poly(L-lactic acid)30, a A3B-type polymer, to form micelles.
This type of micelles has a more densely packed micellar shell structure which can prevent any
penetration through the micellar shells and thereby avoid the interactions with B-cells. However,
the win over the ABC phenomenon is at the cost of reduced half-life time of the micelles in the
bloodstream, which leads to reduced accumulation of micelles in tumors.155 Following the same
idea, nanosheets which have even more densely packed shell structures were prepared by the same
group. Instead of using the same type of copolymer the PLLA was replaced by a helical
polypeptide segment, poly (Leu-Aib), whose secondary structure leads to the formation of
nanosheets. Although the ability to escape liver is not as good as micelles, this type of nanosheet
can also suppress the ABC phenomenon and could accumulate in tumor sites even after multiple
dosages.156
Thanks to all of these systematic studies, scientists now have deeper insights into
aggregation behaviors and biological activities of polypeptoid-based nanoparticles. A remaining
problem is that most of the systems investigated are limited to PNMG, but polypeptoids are much
more than this. More importantly most of these amphiphilic block copolymers have polypeptides
as hydrophobic segments, which are known to exist in solution with helical secondary structures,
so the aggregation behaviors and other biological activities of this polypeptoid-polypeptide coilrod copolymers could be very different from polypeptoid-polypeptoid coil-coil copolymers.
Scientists still need to expand the scopes of polypeptoids that can be used for biomedical
applications and prepare new amphiphilic block copolypeptoids with unique biological activities
for drug delivery. Based on the results of the pharmacokinetics of Lactosome, it seems promising
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that the immune system issue caused by polypeptoid-based micelles can be overcome by corecrosslinking or shell-crosslinking to provide densely packed nanostructures without compromising
their ability to accumulate in tumor.
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Chapter 2. Amidine-Mediated Ring-Opening Polymerization towards Cyclic
Polypeptoids
2.1 Introduction
Polypeptoids, also known as poly (N-substituted glycine)s, are synthetic mimics of
polypeptides. Because of the N-substitution, polypeptoids lack main chain chirality and hydrogen
bonding interaction, in contrast to polypeptides. This results in polypeptoid having enhanced
proteolytic stability relative to polypeptides,157 thermo-processability14, 16, 69 and conformational
tunability (via side chain structure).7, 64, 158, 159 Secondary conformations of polypeptoids including
random coil, helices, sheet structures have all been reported. 160,4, 11, 161, 162 In addition, polypeptoids
have been shown to exhibit minimal cytotoxicity to several cell lines1, 163, 164 and can degrade under
oxidative conditions that mimic the tissue inflammation environment, suggesting the potential uses
for in vivo biomedical applications.165
Cyclic polymers have attracted considerable attention because of their distinctive physical
properties as compared to the linear counterparts. The unique topology imparts many interesting
properties to cyclic polymers such as lower intrinsic viscosity,35, 36 higher glass transition and
melting temperatures,14, 37 faster crystallization rates, 166 and wider phase transition windows,40
relative to the linear counterparts. To date, several synthetic approaches have been developed for
the

cyclic

polymers,

polymerization,36,

54

including

interfacial

condensation,48

end-to-end polymer cyclization,49,

167

ring-expansion

metathesis

and zwitterionic ring-opening

polymerization (ZROP).60-62, 67

*This chapter previously appeared as [Ang Li, Lu Lu, Xin Li, LiLin He, Changwoo Do, Jayne C.
Garno and Donghui Zhang, Amidine-Mediated Zwitterionic Ring-Opening Polymerization of NAlkyl N-Carboxyanhydride: Mechanism, Kinetics and Architecture Elucidation.
macromolecules, 2016, 49 ,1163–1171.] It is reprinted by permission of American Chemical
Society.
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The zwitterionic intermediate can either react with monomers (by a chain growth
mechanism) or with each other (by a step growth mechanism) to elongate the chain or undergo
intramolecular chain transfer to yield a mixture of linear and cyclic polymers (via backbiting
mechanism). Intramolecular chain transfer that occurs exclusively in an end-to-end fashion will
produce macrocyclic polymers cleanly. While the end-to-end macrocyclization is entropically
unfavored, high molecular weight cyclic polymers can be cleanly produced by the ZROP method
when the interactions between the oppositely charged chain ends of the zwitterionic propagating
intermediates overcome the entropic penalties.59 A distinct advantage of the ZROP method is that
the polymerization can be conducted in moderate to high monomer concentration, enabling
efficient access to cyclic polymers. This is in contrast to the end-to-end cyclization strategy of
linear polymer precursors that typically require high dilution conditions.
ZROP has recently emerged as a promising strategy to produce high molecular weight
cyclic polymers with diverse backbone structures (e.g., polyester60-62,63 and polyamide)64. For
example, it was recently reported that isothiourea can mediate the ZROP of lactide to produce
cyclic polylactides with relatively high cyclic polymer contents in spite of somewhat slow
polymerization rates.65 B(C6F5)3 was used as the electrophilic initiator to mediate the ZROP of
glycidyl monomers to yield cyclic polyethers.66 Several recent studies have shown that Nheterocyclic carbenes (NHCs) can initiate and mediate the ZROPs of strained cyclic monomers
(e.g., lactides, caprolactone, and carbosiloxane) to produce high molecular weight macrocyclic
polylactides, polylactones, and polycarbosiloxanes with moderate to high efficiency.60-62, 67 Cyclic
gradient polyesters can be obtained by NHC-mediated ZROP of ε-caprolactone (CL) and δvalerolactone (VL) in a one-pot reaction.68 We have recently demonstrated that a variety of cyclic
poly(N-substituted glycine) (a.k.a. polypeptoids) with varying N-substituents can be obtained by
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NHC-mediated ZROP of the corresponding R-NCA monomers.1, 64, 69, 70 The reactions were shown
to occur in a controlled manner, producing cyclic polypeptoids with well-defined structure,
molecular weight and narrow molecular weight distribution. This is in contrast to early studies on
pyridine/tertiary amine/solvent initiated or thermally initiated ZROPs of Me-NCA which only
produce low molecular weight cyclic poly(N-methyl glycine) (a.k.a. polysarcosine).71-74
1, 8-diazabicycloundec-7-ene (DBU), a bicyclic amidine, is widely used to catalyze
esterification of carboxylic acids168 and controlled ROPs of lactides, lactones, and cyclic
phosphoesters.169-172 The DBU is commonly considered a strong base with weak nucleophilicity.
This view has changed in recent years after DBU was found to be a competent nucleophile that
can undergo nucleophilic addition to dimethyl carbonate and chloroformate.173-176 It was recently
demonstrated that DBU can initiate the ZROP of lactide to produce a mixture of cyclic and linear
polylactide.177
While NHCs can mediate the ZROP of various cyclic substrates, they are air and moisture
sensitive. In an effort to identify and characterize alternative organic-initiators that can outperform
NHCs in mediating the ZROP of R-NCAs to produce cyclic polypeptoids in a controlled manner
and ideally more robust than NHCs, we investigated the DBU as possible initiators for the ZROP
of Bu-NCA monomers. Throughout this project, we investigated the polymerization behaviors,
polymerization kinetics, and the possible architecture of the resulting polypeptoids obtained from
the polymerizations.
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2.2 Materials and Methods
2.2.1 Materials
1, 8-Diazabicycloundec-7-ene (DBU) (Sigma-Aldrich) was dried over CaH2 and purified
by distillation before use. All solvents used were purchased from Sigma-Aldrich and purified by
passing through alumina columns under argon (Innovative Technology, Inc.) and stored under a
nitrogen atmosphere. All other chemicals were purchased from Sigma-Aldrich and used as
received. N-butyl N-carboxyanhydride (Bu-NCA was synthesized by following a reported
procedure.64 Linear poly (N-butyl glycine) (PNBG) was synthesized from primary amine-initiated
polymerization of Bu-NCA using benzylamine initiators by a reported procedure.64
2.2.2 Instrumentation
1

H NMR spectra were recorded on a Bruker AV-400 spectrometer and chemical shifts in

parts per million were referenced to protio impurities in the deuterated solvent (e.g., CDCl3).
Matrix-assisted laser desorption ionization time of flight mass spectra (MALDI-TOF MS) were
collected on a Bruker ProFLEX III in the reflective mode. α-Cyano-4-hydroxycinnamic acid
(CHCA) was used as matrix.
Size-exclusion chromatography (SEC) analyses were performed using an Agilent 1200
system (Gastorr GT-14 degasser, Agilent 1200 series isocratic pump, and auto sampler) equipped
with three Phenomenex 5 μm, 300×7.8 mm columns (100Å, 1000Å and linear), a Wyatt DAWN
EOS multi-angle light scattering (MALS) detector (GaAs 30 mW laser at 690 nm) and a Wyatt
Optilab rEX differential refractive index (DRI) detector with a 690 nm light source. DMF with 0.1
M LiBr was used as eluent at a 0.5 mL∙min-1 flow rate. The column and detector operate at room
temperature. Wyatt Astra 6.0 was used to process all SEC data. The polymer molecular weight
(Mn) and polydispersity index (PDI) were obtained by Zimm-model fit of MALS-DRI data. SEC
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samples were prepared by dissolving the polymer (5 mg) in DMF/ 0.1 M LiBr (1 mL) with slight
heating followed by filtration through a PTFE syringe filter (pore size = 0.2 μm).
2.2.3 dn/dc Measurement
The refractive index increments (dn/dc) of the synthesized polymers were measured by
using the Wyatt’s rEX DRI detector and Astra 6.0 software with dn/dc template. A series of
polymer solutions in 0.1 M LiBr/DMF whose concentrations ranged from 0.050-3.0 mg∙mL-1 were
injected into the DRI detector. The measured refractive indices were plotted versus concentrations,
and the slope from the linear fit of the data is the dn/dc of the polymer. The dn/dc value of the poly
(N-butyl glycine) obtained from DBU-mediated polymerization of Bu-NCA in DMF/0.1 M LiBr
at 25°C and is 0.0797(9) mL∙g-1. 178
2.2.4 Representative procedures for the kinetic study
A predetermined amount of DBU stock solution in toluene-d8 (20 mM each) were added
to a toluene-d8 solution of Bu-NCA (500 μL, 0.075 mmol, 150 mM) at room temperature. The
contents were transferred into a resealable J. Young NMR tube. 1H NMR spectra were collected
every 3 min at 50 °C over the course of four half-lives. Monomer conversion was calculated from
the relative integration of the methylene proton resonance of the monomer and polymer
respectively. It was determined that by the time the first spectra were taken, approximately 3 - 24 %
of the monomer was converted into polymer. Kinetics experiments were repeated at least twice
under identical conditions for each set of polymerization conditions.
2.2.5 Representative procedures for DBU-mediated polymerization of Bu-NCA
Inside a glovebox, Bu-NCA (154 mg, 0.98 mmol) was dissolved in THF (2.45 mL) and a
predetermined amount of DBU/THF stock solution (381 L, 9.8×10-3 mmol, 40 mM) was added
by syringe. The reaction mixture was stirred at 50°C for 16 h under a nitrogen atmosphere and
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quenched by precipitating the polymers in an excess of hexane. The white polymers were isolated
by centrifugation and decantation, and dried under vacuum (100 mg, 91% yield). 1H NMR of poly
(N-butyl glycine) (in CDCl3, ppm): 0.91 (CH3CH2CH2CH2-), 1.31 (CH3CH2CH2CH2-), 1.49
(CH3CH2CH2CH2-), 3.37 (CH3CH2CH2CH2-), 4.00 (-COCH2-).
2.2.6 Representative procedures for convert DBU-PNBG into linear analogs
Inside a glovebox, DBU-PNBG25 (1eq., 27 mg, 9.3 µmol) was dissolved in THF (580 µL),
into which AcCl (10.6 eq., 7 µL, 99 µmol) was added by a micro-syringe. The reaction solution
was stirred at room temperature for 1 h. The solution was then purified by adding the bad solvent,
hexane, in an excess amount, and then dried under vacuum to remove excess AcCl to obtain pure
AcCl-treated DBU-PNBG25.
2.3 Results and Discussion
Scheme 2.1. DBU-mediated ring-opening polymerization of Bu-NCA monomers.

2.3.1 DBU-mediated polymerization of Bu-NCAs
A series of polymerizations of Bu-NCA in the presence of DBU were conducted in 50 °C
THF with varying initial monomer to DBU feed ratios ([M]0: [DBU]0=25:1 to 400:1) at three
different initial monomer concentrations ([M]0= 0.4, 0.8 and 1.6 M). Progression of the
polymerization was monitored by 1H NMR spectroscopic analysis of the reaction aliquots taken at
different time. All reactions were allowed to reach a complete conversion prior to termination by
precipitation of the polymers in hexane.
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The isolated polymers were characterized by 1H NMR, MALDI-TOF MS spectroscopy
and size-exclusion chromatography coupled to multi-angle light scattering and differential
refractive index detectors (SEC-MALS-DRI). 1H NMR analysis revealed the desired PNBG
backbone structure and the presence of DBU moieties affixed to the polymer chains, as evidenced
by the presence of two methylene groups (f, g) of the DBU moieties at 2.84 and 2.05 ppm
respectively (Figure S2.1). MALDI-TOF MS analysis of a low molecular weight polymer revealed
the dominant presence of molecular ions that are consistent with the structures of cyclic PNBG
polymers bearing one DBU moiety (a,b,c and h, Figure S2.2) and the cyclic zwitterionic PNBG
species bearing one DBU moiety and one carbamate end-group (d and e, Figure S2.2) (Scheme
2.1). Minor sets of molecular ions that are consistent with the linear PNBG polymers bearing one
carboxylic acid end group and one secondary amino end-group were also present (f and g, Figure
S2.2). In addition, some of the cyclic PNBG polymers were co-ionized with methanol (the solvent
introduced during the MALDI-TOF MS sample preparation) under the MALDI-TOF MS
conditions (Figure S2.2). Similar behaviors have previously been reported for the MS studies of
the PNBG polymers obtained from the NHC-mediated ZROP of Bu-NCAs.179
SEC-MALS-DRI analysis revealed that PNBGs with predicable Mn values in the 3.5- 32.4
kg∙mol-1 range can be readily synthesized by controlling the initial monomer to DBU ratios ([M]0=
0.4 M, entry1- 7, Table 2.1). The polymer molecular weight distribution remains relatively narrow
(PDI= 1.02-1.03) (Figure 2.1 (A)). The experimental Mn values determined by the SEC analysis
agree reasonably well with the theoretical values based on single site initiation by DBU when the
initial monomer to initiator ratio ([M]0: [DBU]0) is lower than 150:1. However, when the [M]0:
[DBU]0 ratio exceeds 150:1, the experimental Mn values become less than theoretical values,
suggesting side reactions in competition with chain propagation. If the DBU initiates the
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polymerization by a nucleophilic ring-opening pathway, it is conceivable that intra-molecular
macrocyclization or intermolecular head-to-tail chain coupling may occur, resulting in the
formation of free DBUs. The liberated DBU can re-initiate the chain growth, resulting in reduced
polymer molecular weights.
Table 2.1. DBU-mediated polymerization of Bu-NCA in THF with different initial monomer to
initiator ratios ([M]0: [DBU]0) a
Entry
[M]0:
[M]0 b
Mn (theor.) c Time Mn (SEC) d
PDI d
number
[DBU]0
(M)
(kg∙mol-1)
(h) a
(kg∙mol-1)
1
25:1
0.4
2.9
4
3.5
1.08
2
50:1
0.4
5.8
8
5.9
1.10
3
75:1
0.4
8.6
12
8.4
1.02
4
100:1
0.4
11.4
16
9.7
1.05
5
150:1
0.4
17.1
24
14.1
1.08
6
200:1
0.4
22.7
32
18.4
1.08
7
400:1
0.4
45.4
64
32.4
1.04
8
25:1
0.8
2.9
2
3.8
1.12
9
50:1
0.8
5.7
4
5.7
1.10
10
100:1
0.8
11.4
8
9.5
1.06
11
200:1
0.8
22.7
16
16.6
1.02
12
400:1
0.8
45.4
32
19.3
1.11
13
50:1
1.6
5.7
1
4.6
1.07
14
100:1
1.6
11.4
2
8.5
1.04
15
200:1
1.6
22.7
4
15.2
1.02
16
400:1
1.6
45.4
8
26.5
1.03
a.
All reactions were conducted in 50°C THF for different duration (1- 64 h) to reach complete
conversions; b .the initial monomer concentration; c. the theoretical polymer molecular weight is
calculated using the initial monomer to DBU ratio ([M]0: [I]0) assuming a single-site initiation by
DBU and complete conversions; d. experimental polymer molecular weights were obtained by
SEC-MALS-DRI method (DMF/0.1M LiBr, 25°C) with a measured dn/dc=0.0797(9) mL∙g-1.
Alternatively, residual nucleophilic impurity such as H2O can also initiate the
polymerization, giving rise to reduced polymer Mns than theoretical values, consistent with the
MALDI-TOF MS results suggesting the presence of PNBGs comprised of one carboxylic endgroup and one secondary amino end-group in low apparent content. Controlled experiments
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showed that while H2O can initiate the polymerization of Bu-NCA under the standard
polymerization conditions (i.e., [M]0: [H2O]0= 50:1, THF, 50°C), the initiation is significantly
slower than that by other nucleophilic initiators (e.g., primary amine or DBU). This is supported
by the much longer reaction time to reach complete monomer consumption and the significantly
higher polymer molecular weight of the resulting PNBG when water is the initiator than when
primary amine or DBU are used as initiators. It was also noted that polymerization conducted at
higher initial monomer concentration ([M]0= 0.8 or 1.6 M) and initial monomer to initiator ratio
([M]0: [DBU]0= 400:1) (Entry 12 and 16, Table 2.1) yielded PNBG polymers whose Mn deviate
more significantly from the theoretical value than that from the lower initial monomer
concentration (Entry 7, Table 2.1). The origin for the deviation is presently unclear.
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Figure 2.1. (A) Representative normalized SEC chromatograms of PNBG obtained at varying
initial monomer to initiator ratios (Entry 1-7, Table 2.1). (B) Plots of experimental Mn (■) and PDI
(●) versus conversion of DBU-mediated polymerization of Bu-NCA ([M]0: [I]0= 100:1, [M]0= 0.4
M, 50oC, THF), the linear fit of the Mn versus conversion plot (—) (R2 = 0.98) and theoretical
trend line of a living polymerization (∙∙∙).
The polymer molecular weight was found to increase linearly with conversion during the
DBU-mediated polymerization of Bu-NCA in THF (Figure 2.1 (B)). The polymer molecular
weight distribution also remains narrow PDI (PDI= 1.02-1.12) throughout the polymerization.
However, the Mn versus conversion plot does not go through the (0,0) origin, suggesting that the
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rate of initiation is either comparable to or slower than that of the propagation in the polymerization.
1

H NMR analyses of the polymerization reaction mixtures upon reaching quantitative conversion

revealed the absence of any free DBU initiators, suggesting that all DBUs ultimately became
incorporated into the polymer chains through initiation.
Solvent effect on the Mn and PDI control of the polymerization was investigated by
conducting DBU-mediated polymerizations of Bu-NCA with various initial monomer to DBU
ratios in a less polar solvent (toluene) and a more polar solvent (DMF) relative to THF. In toluene,
the DBU-mediated polymerization of Bu-NCA exhibited a similar level of control over Mn and
PDI as those conducted in THF (Table S2.1). By contrast, polymerization of Bu-NCA in DMF
under identical conditions produced only low molecular weight PNBGs in the 0.5- 4.3 kg∙mol-1
albeit with narrow molecular distribution (PDI= 1.04-1.11) (Entry 5-9, Table S2.1). We attributed
this to the competitive intramolecular backbiting by transamidation relative to chain propagation
in DMF. The liberated DBU can re-initiate chain propagation, leading to high monomer conversion
but low polymer molecular weight. This is supported by MALDI-TOF MS analysis of the resulting
polymers, which consist of mainly cyclic PNBGs without DBU attached and minor cyclic PNBGs
having one DBU moiety attached.
2.3.2 Kinetic study of DBU-mediated polymerization of Bu-NCA
We investigated the polymerization kinetics by conducting the DBU-mediated
polymerization of Bu-NCA in toluene-d8 at 50°C with a constant initial monomer concentration
([M]0= 0.15 M) and varying initial monomer to initiator ratios ([M]0: [DBU]0= 25:1-150:1, Figure
2.2 (A)). The plot of ln([M]0:[M]) versus time for all reactions can be linearly fitted quite well,
indicating that the polymerization is first-order dependent on the monomer concentration. The
slope of the linear fits afforded the observed polymerization rate constants (kobs) at different DBU
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loading. The plot of kobs versus the initial DBU concentration (Figure 2.2 (B)) can also be linearly
fitted, indicating that the polymerization is also first-order dependent on the initiator concentration
with a second-order propagating rate constant (kp) of 5.05±0.09 M-1∙min-1. A close inspection of
the ln([M]0: [M]) versus time plots revealed a slightly concaved shape at the initial stage of the
reactions, suggesting the initiation rate is either comparable to or slower than the rate of
propagation. Thus, the kp obtained by the above kinetic analysis is somewhat approximate. To
determine the relative initiation and propagation rate, a kinetic model that describes a living
polymerization with slow initiation relative to propagation was further used to analyze the
conversion versus reaction time plot for a selected polymerization ([M]0: [DBU]0 = 150:1, 50°C,
toluene-d8).180 The plot of the concentration of consumed monomers ([M]p) within the initial 25%
conversion versus time exhibits good linearity (Figure 2.2 (C)). The model fitting of the kinetic
data yields an initiation rate constant (ki= 3.22±1.29 M-1∙min-1) that is nearly identical to the
propagation rate constant (kp= 2.38±0.03 M-1∙min-1). To further validate these rate constants, plot
of conversion versus time up to 80 % conversion was also fitted using the kinetic model (Figure
2.2 (D)), which gives the propagation rate constant of kp = 2.36±0.07 M-1∙min-1 on par with the kp
obtained by fitting the [M]p versus time plot in the initial 25% conversion range (Figure 2.2 (B)).
As a result, the kinetic study suggests that the DBU-mediated polymerization of Bu-NCA
undergoes the initiation event that is comparable in rate relative to propagation. The propagation
rate is slightly faster than that of the previously studied ZROP of Bu-NCA using NHC initiators
(kp =1.53±0.10 M-1∙min-1).70 The difference in the propagation rate constant in the two systems
can be attributed to the difference of counter-ion effect in the zwitterionic propagating
intermediates (Scheme 2.1). DBU moieties on the cyclic zwitterionic propagating intermediate is
less sterically demanding than the NHC moieties, thereby allowing for slightly faster addition of
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the monomer to the zwitterionic chain ends and a faster propagation rate in the former than the
latter.
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Figure 2.2. (A) Plots of ln([M]0:[M]) versus time for DBU-mediated polymerization of Bu-NCA
in toluene-d8 at 50 oC and the linear fitting of the data (—); (B) plot of observed polymerization
rate constants (kobs) versus the initial DBU concentration and the linear fitting of the data (—) (R2
= 0.998); (C) plot of concentration of polymerized Bu-NCA ([M]p) versus reaction time of DBUmediated polymerization within the first 25% conversion ([M]0=0.15 M and 50°C in toluene-d8);
(D) plot of conversion of DBU-mediated polymerization of Bu-NCA versus reaction time of DBUmediated polymerization of Bu-NCA up to 80% conversion. The red lines in C and D are the fitting
of the data (C: R2 = 0.997; D: R2 = 0.983) using a kinetic model describing a living polymerization
with slow initiation relative to propagation.
2.3.3 Chain extension experiment
An important feature of controlled polymerization is the living characteristic of the
propagating intermediates, allowing for chain extension with additional monomers. Two chain
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extension experiments were conducted using two PNBG macroinitiators with different chain
length (DP= 25 and 200) prepared by the DBU-mediated polymerization of Bu-NCA. Additional
Bu-NCA ([M]0: [PNBG]0=65:1 and 350:1) was introduced into the PNDG25 and PNDG200
macroinitiators respectively. Both reactions (in 50°C THF) were allowed to reach a complete
conversion. SEC analysis of the PNBG polymers after the reaction revealed a single peak with low
PDI (Table 2.2) at a shorter elution time relative to the PNBG macroinitiator precursor (Figure
S2.3), confirming the success of the chain extension and the living characteristic of the PNBG
precursors. While PNBG produced by DBU-mediated polymerization of Bu-NCA can be further
enchained, the control of the resulting polymer chain length appears to be dependent on the
polymer molecular weight range. For example, chain extension produces PNBG polymers whose
molecular weight agrees reasonably well with the theoretical values based on efficient initiation
by the PNBG macroinitiators at the low PNBG molecular range (DP < 100, Table 2.2, Entry 1).
At the high MW range (DP > 100), the MW of the resulting polymer is substantially lower than
the theoretical value after the chain extension, suggesting the presence of competing side reactions.
Table 2.2. Chain extension polymerization from DBU-terminated PNBG macroinitiatorsa
Entry
number

Experiment

[M]0:[I]0

Mn (theor.)
(kg∙mol-1)

Mn (SEC) b
(kg∙mol-1)

PDI b

1

Before Chain Ext.

25

3.0

3.0

1.10

After Chain Ext.

90

10.2

9.2

1.02

Before Chain Ext.

200

22.7

17.2

1.05

After Chain Ext.

550

62.3

37.4

1.10

2
a.

All polymerization reactions were allowed to reach complete conversion; b. the measured Mn and
PDI were obtained by the SEC-MALS-DRI method (DMF/0.1 M LiBr, 25°C) with a measured
dn/dc=0.0797 (9) mL∙g-1.
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Scheme 2.2. End-group treatment of DBU-PNBG25 with AcCl.

2.3.4 Architecture assessment
It was reported before that NHC-mediated ZROP of Bu-NCA undergoes a
spirocyclic/zwitterionic propagating intermediate, so the cyclic polypeptoids can be converted into
linear counterparts by end-group treatment using acetyl chloride (AcCl).181 If DBU-mediated ROP
of Bu-NCA monomers follows the similar chain propagating mechanism, it is conceivable that
cyclic polypeptoids can also be produced through this pathway, and the linear counterparts of
DBU-PNBGs can be obtained by AcCl-treatment as well. To test this hypothesis, a PNBG 25-mer
was synthesized by DBU-mediated polymerization of Bu-NCA monomers and then treated with
AcCl in excess at room temperature for 1 h in THF (Scheme 2.2). The PNBG sample was then
purified by precipitation in hexane (a bad solvent) and dried under vacuum to remove residual
AcCl. The 1H NMR analysis of the resulting polymers indicated the successful attachment of acetyl
group to the PNBG polymers, evidenced by the appearance of acetyl proton at 2.1 ppm and the
downfield shift of methylene protons of the DBU moieties (f) from 2.8 to 3.0 ppm due to the
positive charge generated at the adjacent carbon (Figure S2.4). End-group analysis by MALDITOF MS (Figure S2.5) also revealed that the major set of mass ions corresponds to the positively
charged DBU-PNBGs end-capped with acetyl groups, in agreement with the 1H NMR result.
Minor sets of mass ions observed in MALDI-TOF MS spectrum correspond to unreacted DBUPNBGs and water-initiated DBU-PNBGs end-capped with acetyl groups. Mn values of DBUPNBG25 and AcCl-treated DBU-PNBG25 were obtained from MALDI-TOF-MS analysis too. The
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Mn of DBU-PNBG25 is 2683 g·mol-1 (PDI= 1.05), which is slightly smaller than the Mn of the
sample after AcCl-treatment (2704 g·mol-1, PDI= 1.06). SEC analysis of DBU-PNBG and the
resulting polymer after AcCl treatment (Figure 2.3) revealed that the latter exhibits a shorter
elution time relative to the former, suggesting a larger hydrodynamic volume of the latter than the
former sample. This is consistent with the proposed architectural change of cyclic DBU-PNBGs
into the linear analogs. The low molecular weight shoulder in the acetyl end-capped PNBGs is
attributed to the unreacted DBU-PNBG precursors.
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Figure 2.3. SEC chromatograms of DBU-PNBG25 and AcCl-treated DBU-PNBG25 in 0.01M
LiBr/DMF.
2.3.5 Investigation of the initiation event
To gain insights into the initiation step of the DBU-mediated polymerization of R-NCAs,
DBU and Bu-NCA in a 1:1 stoichiometric ratio was allowed to react in THF at 50°C for 2 h. 1H
NMR analysis revealed the complete disappearance of the reactants. The product was isolated as
a brownish solid by precipitation in hexane.
The resulting product was analyzed by ESI-MS (electrospray ionization mass spectrometry)
in positive ionization mode. Two molecular species whose mass are consistent with cyclic trimeric
or tetrameric N-butyl glycine N-carboxyanhydride species are observed in the ESI-MS spectrum
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(Figure S2.6). This agrees with the kinetic analysis, which revealed an initiation step that is
comparable in rate to propagation. This makes isolation of initiating species challenging. Apart
from these two species, a third molecular ion consistent with the protonated DBU is also present
in the ESI-MS spectrum. The species observed in ESI-MS analysis differ from what was observed
in the MALDI-TOF MS analysis of a low molecular PNBG (DP= 25) obtained from DBUmediated polymerization of Bu-NCA where the major molecular ions are due to the cyclic PNBGs
bearing one DBU moiety. The discrepancy may arise from the difference in MS conditions:
electrospray ionization can cause elimination of the initiating moieties (i.e, DBU in this study)
from the cyclic zwitterionic polymeric species as previously demonstrated in the detailed MS
studies of cyclic PNBG polymers obtained from NHC-mediated ZROP of Bu-NCAs.179
FT-IR (Fourier transform infrared spectroscopy) analysis of the species obtained from the
1:1 molar ratio reaction of DBU and Bu-NCA further confirms the formation of zwitterionic
species in the initiation event (Figure S2.7). The peak at 1572 cm-1 is due to the carbonyl stretch
of the carbamate group at the chain end,70, 182, 183 which is consistent with the molecular ions
observed by the ESI-MS analysis of the reaction mixture. The peak at 1684 cm-1 is due to the
amide carbonyl group of the PNBG backbone. The amide peak that is immediate adjacent to the
cationic DBU moiety is blue-shifted to at 1755 cm-1 presumably due to the inductive effect of the
cationic DBU moiety. The peak at 1646 cm-1 and 1613 cm-1 are due to C= N stretching mode of
the positively charged DBU-moiety and the unreacted DBU, respectively.184, 185 As a comparison,
the FTIR spectrum of the species obtained from the reaction of benzyl amine (BnNH2) and BuNCA in a 1:1 molar ratio exhibits only one carbonyl peak (1680 cm-1) which is due to the amide
carbonyl of the linear PBNG backbone, clearly indicating a different initiation and propagation
mechanism from that of the DBU-mediated polymerization of Bu-NCA.
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It is proposed that DBU initiates the polymerization by nucleophilic ring-opening addition
of Bu-NCA at the 5-carbonyl position to form the zwitterionic initiating species 1 (Scheme 2.3).
The chain propagation ensues by Bu-NCA monomer addition at the carboxylate end of 1 to form
the intermediate species 2. The carboxylic-carbamic anhydride linkages in 2 is thermally labile
and readily undergoes intramolecular decarboxylation to yield 3, which has been observed
spectroscopically in the early studies of small model compounds.186, 187 Species 3 can undergo
decarboxylation to form 4, which is observed in the MALDI-TOF MS analysis.
Scheme 2.3. Proposed initiation and propagation mechanism of DBU-mediated ZROP of R-NCA
monomers.

We propose that the decarboxylation is reversible, allowing 4 to regain CO2 to form 3, from
which monomer addition and chain propagation ensue. This is consistent with the living
polymerization characteristics of the DBU-mediated polymerization of Bu-NCA. The formation
of species 5 presumably from macrocyclizaion of 3 is supported by the ESI MS analysis. Its
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formation is not kinetically competitive relative to monomer addition, thus giving rise to the
controlled polymerization behavior. Furthermore, the methylene proton on the cationic DBU endgroup that is adjacent to the positively charged carbon is sufficiently acidic to be deprotonated by
anionic alkoxide, as shown in a previous study of DBU-mediated zwitterionic polymerization of
lactide, resulting in the formation of linear polylactide impurities.177 In this study, we do not
observe the deprotonation of the methylene protons in the DBU end-group based on the 1H NMR
analysis of the 1:1 reaction of Bu-NCA and DBU. This is presumably due to the reduced basicity
of the anionic carbamate chain end relative to the alkoxide species.
2.4 Conclusions
DBU-mediated ZROPs of Bu-NCAs exhibit characteristics of a controlled polymerization,
producing poly (N-butyl glycine) with controlled polymer molecular weight (3.5- 32.4 kg∙mol-1)
and narrow molecular weight distribution (PDI < 1.2). The growing chain ends can be successfully
extended with additional monomers, making it useful for the block copolypeptoid synthesis.
Kinetic studies revealed that the initiation rate is comparable to the propagation rate in the DBUmediated ZROP of Bu-NCA, which is slightly faster than previously reported NHC-mediated
ZROP. This is presumably due to the steric difference of the DBU versus the NHC moieties in the
respective cyclic zwitterionic propagating intermediate. End-group analysis using 1H NMR and
MALDI-TOF-MS and SEC analysis of DBU-PNBGs and AcCl-treated DBU-PNBGs suggested
the cyclic architecture of DBU-PNBGs. The enhanced robustness and availability of DBU relative
to NHCs and the excellent control over the polymerization of R-NCA makes the reported method
an attractive route towards well-defined cyclic polypeptoids with tunable ring sizes.
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2.5 Supplementary Data
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Figure S2.1. A representative 1H NMR spectrum of the low molecular weight poly(N-butyl-glycine)
in CDCl3 obtained by the DBU-mediated polymerization of Bu-NCA.
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Figure S2.2. A representative MALDI-TOF MS spectrum of low molecular weight PNBG
obtained by DBU-mediated polymerization of Bu-NCA in 50°C THF.
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Table S2.1. DBU-mediated polymerization of Bu-NCA in different solvents at varying
initial monomer to initiator ratios.
Mn
Mnb (SEC)
PDIb
-1
(kg∙mol )
（Theor.）
-1
(kg∙mol )
1
50:1
Toluene
5.8
5.7
1.08
2
100:1
Toluene
11.4
9.7
1.01
3
200:1
Toluene
22.7
15.4
1.05
4
400:1
Toluene
45.4
28.4
1.04
c
5
5:1
DMF
0.7
0.5
1.04c
6
10:1
DMF
1.3
1.9
1.06
7
50:1
DMF
5.7
3.0
1.07
8
100:1
DMF
11.4
4.3
1.11
9
200:1
DMF
22.7
3.3
1.04
a.
All the polymerizations were conducted at 0.4M initial monomer concentration at 50°C. All
the polymerizations were allowed to reach complete conversion based on 1H NMR
spectroscopy; b. Mn values were obtained by SEC-MALS-DRI system in DMF/0.1M LiBr with
a measured dn/dc=0.0797(9) mL∙g-1;c Mn and PDI were obtained by ESI-MS analysis.
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Figure S2.3. SEC chromatograms of PNBG obtained by DBU-mediated polymerization of BuNCA and chain-extension experiment in THF at 50°C. (A)The PNBG precursor was synthesized
with [M]0: [I]0=25:1(—) and the chain-extension experiment was conducted with [M]0:
[I]0=65:1(—). (B) The PNBG precursor was synthesized with [M]0: [I]0=200:1(—) and the chainextension experiment was conducted with [M]0: [I]0=350:1
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Figure S2.4. A representative 1HNMR spectrum of DBU-PNBG25 obtained after AcCl treatment
in CDCl3.
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Figure S2.5. A representative MALDI-TOF MS spectrum of AcCl-treated PNBG25.
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Figure S2.6. A representative ESI-MS spectrum of the product obtained from the reaction of DBU
and Bu-NCA in a 1:1 initial molar ratio. The ESI-MS experiment is conducted in positive mode.
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Figure S2.7. Representative FTIR spectra of the product in THF solution obtained from the
reaction of Bu-NCA with DBU (—) or BnNH2 (—) in a 1:1 initial molar ratio, respectively.
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Chapter 3. Solution Aggregation of Cyclic Polypeptoids Obtained
from Amidine-Mediated Zwitterionic Ring-Opening Polymerization
3.1 Introduction
Polypeptoids, also known as poly (N-substituted glycine)s, are synthetic mimics of
polypeptides. Because of the N-substitution, polypeptoids lack main chain chirality and hydrogen
bonding interaction, in contrast to polypeptides. The N-substitution results in enhanced proteolytic
stability,157 thermo-processability14, 16, 69 and conformational tunability (via side chain structure)
relative to polypeptides,7,

64, 158, 159

making polypeptoids good candidates for biomedical

applications.
Cyclic polymers have attracted considerable attention because of their distinctive physical
properties as compared to the linear counterparts. The unique topology imparts many interesting
properties to cyclic polymers such as lower intrinsic viscosity,35, 36 higher glass transition and
melting temperatures,14, 37 faster crystallization rates, 166 and wider phase transition windows,40
relative to the linear counterparts. Regarding biomedical applications, it was found that the ring
architecture of cyclic polymers facilitates higher gene transfection efficiency than their linear
counterparts do presumably due to their more compact conformations and stronger interactions
with DNA molecules.47 To date, several synthetic approaches have been developed for the cyclic
polymers, including interfacial condensation,48 ring-expansion metathesis polymerization,36,

54

end-to-end polymer cyclization,49, 167 and zwitterionic ring-opening polymerization (ZROP).60-62,
67

The progressed synthetic approaches allow for the production of more sophisticated ring-

structures which may endow the resulting materials with more exciting properties. It was reported
recently that eight-shaped amphiphilic copolymers,55 multi-complex cyclic polymers,56, 57 and
stereocomplex of cyclic syndiotactic Poly(methyl methacrylate) (PMMA) and linear isotactic
PMMA

58

can be synthesized.
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Polymers with long side chains are usually considered bottlebrush polymers. The unique
bottlebrush structure imparts distinctive properties to the polymers. It was demonstrated that linear
bottlebrush polymers can be used for water lubrication.188 The water lubricant can be acquired by
absorption of the bottlebrush backbones onto the substrate and the immobilization of large amount
of water within the densely packed side chains. When the two substrates are compressed against
each other, the inter-chain repulsion and the immobilized solvent lead to the formation of a
cushioning layer, and therefore the friction between the two slides can be drastically alleviated.
Besides absorbing small molecules, the densely grafted long side chains can also provide stealth
properties to the polymer backbones and the grafted small molecules. Grubbs et al. synthesized
stimuli-responsive linear bottlebrush polymers based on the polynorbornene backbones grafted
with long PEG side chains and drug molecules. Cytotoxicity study revealed that upon UVtriggered drug release the cytotoxicity of bottlebrush polymers is similar to that of small drug
molecules but much higher than that of the drug-bottlebrush polymer complex without UVresponsive behaviors, indicating excellent stealth properties of the linear bottlebrush polymers.189
Rzayev et al. have demonstrated that linear bottlebrush polymers with amphiphilic side chains can
be used to produce tubular nanotubes by first cross-linking the shell of the linearly aligned
bottlebrush polymers and then degrading the inner core. 190 In addition to the structural advantages,
synthesis of linear bottlebrush polymers is another pathway to access high molecular weight
polymers in the condition that the homopolymers with only limited molecular weight can be
produced. For example, Thelakkat et al. synthesized the linear bottlebrushes (poly(3hexylthiophene) (P3HT)) that have much higher molecular weight than the traditional homo-P3HT.
It was found that the thin films formed by the high molecular weight bottlebrush P3HT have better
thermal stability than those formed by the linear counterparts without sacrificing electronic
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properties.191 As to surface patterning bottlebrush polymers have also exhibited the potential to
fabricate advanced biosensors because the three dimensional layers formed by vertically
immobilized brush polymers allow more small molecules to penetrate through and provide more
binding sites than the self-assembled monolayers do, resulting in high sensitivity.192
Combination of the two unique architectures into one single molecule results in a new
polymer structure- cyclic bottlebrush, which could open a new scope of material science and
engineering, and the potential unique properties of this new type of polymers are waiting to be
explored. Our group has demonstrated that cyclic bottlebrush polypeptoids can be synthesized by
zwitterionic ring-opening polymerization (ZROP) using NHC as an initiator. However, NHCs are
air and moisture sensitive, and they used to be the only organo-catalyst to produce cyclic
polypeptoids. In an effort to identify and characterize alternative organo-catalysts that can
outperform NHCs in mediating the ZROP of R-NCAs to produce cyclic polypeptoids in a
controlled manner and ideally more robust than NHCs, we investigated the 1, 8diazabicycloundec-7-ene (DBU), a bicyclic amidine. DBU is widely used to catalyze esterification
of carboxylic acids193 and controlled ROPs of lactides, lactones, and cyclic phosphoesters. It was
recently demonstrated that DBU can initiate the ZROP of lactide to produce a mixture of cyclic
and linear polylactides.177 Our previous study (Chapter 2) suggested that well-defined cyclic
polypeptoids can be synthesized by DBU-mediated ZROP of R-NCAs. In this study, cyclic
bottlebrush polypeptoids were synthesized through the new pathway with the new initiator.
Analysis of cyclic polymers can be divided into qualitative analysis and quantitative
analysis. For cyclic Gaussian chains, their intrinsic viscosity, hydrodynamic radius or radius of
gyration have a specific theoretical relationship relative to the linear counterpart. This relationship
is called characteristics ratio. For example, it was reported that the ratio of the intrinsic viscosity
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of cyclic and linear polystyrene (PS) in the  conditions is close to 0.65.194 By measuring the
characteristics ratio of the polymers of interests versus the linear polymer analogs under 
conditions, one can determine whether the former polymers have cyclic architectures. When 
conditions are not met, this method provides only qualitative results for the architectural analysis.
It was previously demonstrated that the atomic force microscopy (AFM) can be used to verify the
polymer backbone architecture including cyclic backbone.75-80 On the other hand, microscopic
analysis and scattering analysis provide accurate dimensions of cyclic polymers. Especially when
small angle x-ray scattering (SAXS) or small-angle neutron scattering (SANS) are used for the
analysis, physical parameters including radius of gyration, persistence length, Kuhn length, etc.
can usually be determined. For example, quantitative analysis of a worm-like chain (cyclic
amylose tris(phenylcarbamate) (c-ATPC)) was conducted by fitting the Holtzer plots obtained by
SAXS measurement using the scattering function of a cylindrical rigid ring. It revealed that the
helix pitch per residue and the Kuhn segment length of the rigid rings are independent of the
solvent, which is opposite to the linear analog, indicating that rigid cyclic polymers have different
local conformation from linear polymers.81 The SANS study on the absorption of cyclic poly
ethylene glycol (PEG) onto silica particles has shown that cyclic PEG has higher absorption on
silica nanoparticles than the linear analog does, but the thickness of the cyclic PEG layer decreases
as the molecular weight increases, which is very different from the linear PEG.82 More similar
analyses of cyclic polymers have been conducted, and deeper and deeper understanding of cyclic
polymers will be obtained through these studies.
A good platform has already been established for the analysis of any type of cyclic
polymers. As the synthetic approaches become developed, cyclic bottlebrush polypeptoids can be
produced readily in a controlled manner. The densely grafted side chains can rigidify the cyclic
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backbone conformation, making microscopic analysis of cyclic polymers possible in both dry state
and solution phase. On the other hand, the progressed analytical methods including SAXS or
SANS are powerful tools for the characterization of cyclic polymers so that unique properties of
the cyclic bottlebrush polypeptoids can be revealed.
The physical properties and solution behaviors of the emerging cyclic bottlebrush
polypeptoids were systematically investigated using advanced analytical methods and
computational simulation.
3.2 Materials and Methods
3.2.1 Materials
1, 8-Diazabicycloundec-7-ene (DBU) was dried over CaH2 and purified by distillation
before use. All solvents used were purchased from Sigma-Aldrich and purified by passing through
alumina columns under argon (Innovative Technology, Inc.) and stored under a nitrogen
atmosphere. All other chemicals were purchased from Sigma-Aldrich and used as received. Nbutyl N-carboxyanhydride (Bu-NCA), N-propargyl N-carboxyanhydride (Pg-NCA), and N-methyl
N-carboxyanhydride (Me-NCA) were synthesized by following reported procedures.75, 195, 196 All
cyclic and linear poly (N-methyl glycine) (c-PNMG and l-PNMG) bearing a DBU initiating moiety
as well as the cyclic and linear bottlebrush copolymers bearing poly(N-butyl glycine-r-N-propargyl
glycine) backbone and polyethylene glycol (PEG, Mn= 550 g∙mol-1) and butyl sidechains (in a 6:1
molar ratio) [c-P(NBG-r-NPgG)-g-PEG and l-P(NBG-r-NPgG)-g-PEG] were synthesized and
characterized by using previously reported procedures. 195, 197
3.2.2 Instrumentation
1

H NMR spectra were recorded on a Bruker AV-400 spectrometer and chemical shifts in

parts per million were referenced to protio impurities in the deuterated solvent (e.g., CDCl3).
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Size exclusion chromatography (SEC) analyses were performed using an Agilent 1200
system (Gastorr GT-14 degasser, Agilent 1200 series isocratic pump, and auto sampler) equipped
with three Phenomenex 5 μm, 300×7.8 mm columns (100Å, 1000Å and linear), a Wyatt DAWN
EOS multi-angle light scattering (MALS) detector (GaAs 30 mW laser at 690 nm) and a Wyatt
Optilab rEX differential refractive index (DRI) detector with a 690 nm light source. DMF with 0.1
M LiBr was used as eluent at a 0.5 mL∙min-1 flow rate. The column and detector operate at room
temperature. Wyatt Astra 6.0 was used to process all SEC data. The polymer molecular weight
(Mn) and polydispersity index (PDI) were obtained by Zimm-model fit of MALS-DRI data. SEC
samples were prepared by dissolving the polymer (5 mg) in DMF/ 0.1 M LiBr (1 mL) with slight
heating followed by filtration through a PTFE syringe filter (pore size = 0.2 μm).
3.2.3 AFM sample preparation and experimental procedures
Polymer samples were diluted in chloroform (0.002 mg∙mL-1) and a 5 μL drop was placed
on freshly cleaved mica (0001). The sample was dried and stored in ambient conditions before
AFM analysis. A model 5420 scanning probe microscope from Keysight Technologies (Santa
Rosa, CA) was used to characterize samples of the cyclic polymers using tapping-mode AFM.
Images were acquired using Picoview v1.12. Probes from App Nano (ACTA, Mountain View, CA)
were used for tapping-mode AFM studies in ambient conditions. The tip was driven to oscillate at
a driving frequency of 315 kHz. Images were processed using Gwyddion, an open source software
which is supported by the Czech Metrology Institute.178
3.2.4 SANS sample preparation and experimental procedures
The small-angle neutron scattering (SANS) experiments were performed at GP-SANS
HFIR198 and EQ-SANS SNS199 in Oak Ridge National Laboratory. The scattering profile of the
cyclic bottlebrush polymer was measured at GP-SANS using a fixed wavelength at 4.75 Å
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combined with the sample-to-detector distance (SDD) at 1 m and 12 m, and the corresponding Q
range is 0.006 - 0.6 Å-1. The scattering profile of the linear bottlebrush polymer was measured at
EQ-SANS using the wavelength band of 10.11 < < 13.2 Å at SDD = 4 m and 4.24 < < 7.71 Å
at 1.3 m, with the Q range covering 0.005 - 0.5 Å-1. The polymers were directly dissolved in
deuterated methanol at 1wt% concentration at room temperature. The solution samples were
loaded into 1 mm thick banjo cells for measurements and the transmissions of all the samples are
larger than 0.9. The scattering intensities were scaled to absolute values on the basis of standard
sample measurements (Al-4 and Porsil B).
3.2.5 Cryo-Transmission electron microscopy
Sample preparation for Cryo-TEM was carried out on FEI Vitrobot. The bottlebrush
copolymer was dissolved in methanol (7mg/ml) and then passed through a 0.45um filter. 12ul of
the solution was applied to a 300-mesh lacey carbon grid. Excess liquid was blotted by filter papers
for 2 seconds to form a thin film prior to vitrification in liquid ethane. The sample was then loaded
to a cryo specimen holder and imaged on S1032_FEI G2 F30 Tecnai TEM operated at 100kV.
3.2.6 Dynamic light scattering (DLS)
DLS was conducted on a Brookhaven Instrument (90 Plus PALS) whose laser wavelength
is 640 nm. DLS data was collected by BIC particle solutions software (version 3.1) and analyzed
using CONTIN method. Lognormal median diameters which were reported as effective diameters
and averaged size distributions were obtained from triplicate measurements. DBU-initiated
PNMGs (targeted DP= 100) and DBU-initiated bottlebrush polypeptoids (targeted DP= 100) and
their relevant linear analogs obtained by AcCl-treatment were dissolved in MeOH (6.0- 6.3 mg/mL)
and then filtered through hydrophilic filters (0.1 µm) into clean cuvettes before DLS measurement.
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3.2.7 Representative procedures for the synthesis of the cyclic bottlebrush polypeptoids
In a glovebox, N-propargyl NCA (50 mg, 0.36 mmol) and N-butyl NCA (13 mg, 0.07 mmol)
were dissolved in anhydrous THF (510 µL THF). A stock solution of DBU in THF (24 uL, 2.25
µmol, 95.2 mM) was added to the reaction flask. The flask was sealed and stirred at 50 oC for 2 d.
The polymerization was terminated by adding cold hexane (8 mL). The precipitated polymer was
isolated by decantation and dried under vacuum (36 mg, 83% yield). 1H NMR (in CDCl3, ppm):
0.91 (CH3CH2CH2CH2-), 1.31 (CH3CH2CH2CH2-), 1.50 (CH3CH2CH2CH2-), 2.38
(CHCCH2-), 3.39 (CH3CH2CH2CH2N-), 4.64- 3.90 (-COCH2N-).
Inside a glovebox, the previously synthesized D-PNBG41-r-PNPgG177 (15.6 mg,
[propargyl]0 = 0.13 mmol) and PEG-N3 (105 mg, 0.18 mmol, Mn = 550 g·mol-1, PDI = 1.05, [N3]0:
[propargyl]0 = 1.4:1) were both dissolved in CH2Cl2 (910 µL). A measured volume of CH2Cl2
stock solution containing CuBr/PMDETA (175 µL, 0.043 mmol, 247 mM, [Cu]0: [PMDETA]0:
[propargyl]0 = 33:33:100) was added to the solution which was then stirred at 40 oC for 3 h. The
reaction mixture was then passed through a silica column. The solvent of the filtrate was then
pumped off under vacuum to yield the cyclic bottlebrush polymers. (36 mg, 40% yield, grafting
density: 81%). 1H NMR (in CDCl3, ppm): 3.63 (-CH2CH2O-), 3.88 (-NCH2CH2O-), 4.55 (CCH2N-, -NCH2CO-), 7.97 (-NCHC-).
3.2.8 Representative procedures for the synthesis of the cyclic PNMG bearing a DBU initiating
moiety (D-PNMG)
In a glovebox, Me-NCA (33 mg, 0.29 mmol) was dissolved in anhydrous acetonitrile (700
µL). A stock solution of DBU in THF (30 µL, 2.9 µmol, 95.2 mM) was added to the reaction flask.
The flask was sealed and stirred at room temperature for 16 h. The polymerization was terminated
by adding hexanes (8 mL). The precipitated polymer was isolated by decantation and dried under
vacuum (18 mg, 86% yield). 1H NMR (in CDCl3, ppm): 1.06- 0.76 (CH3CH2-), 1.58-1.21 (- 53 -

CH2CH2CH2-, CH3CH2-), 2.62- 2.25 (-CCH), 3.51-3.20 (-CH2CH2N-), 4.64- 3.90 (-CCH2N-, NCH2CO-, -NCH2CO-).
3.2.9 Representative procedures for the synthesis of the linear PNMG bearing a DBU initiating
moiety (D-PNMG-Ac)
In a glovebox, the cyclic PNMG bearing a DBU initiating moiety (10 mg, 87 µmol) was
dissolved in anhydrous THF (250 µL). A THF stock solution of acetyl chloride (AcCl) (156 µL,
0.14 µmol, 0.9 M) was added to the reaction flask. The flask was sealed and stirred at room
temperature for 16 h. The volatiles were removed under vacuum to yield the final polymer product
(10 mg, 100 % yield).
3.2.10 Computations
Computational studies were carried out on the linear and the cyclic counterpart of the
PNMG100 polypeptoid in methanol solvent. In the cyclic case, the two ends are represented by
oppositely charged groups, namely -O- and -NH3+ whereas in the linear case the end groups are –
OH and -NH3+. While these are not the end groups in the actual peptoids, they carry the appropriate
charge and hence present a reasonable representation of the relevant end group interactions.
3.2.10.1 Molecular dynamics (MD) simulations
The initial configuration of each of the two types of peptoid oligomers were generated by
connecting 100 monomers with methyl side chains. The OPLSAA force field parameters for the
Lennard-Jones and intramolecular interactions were used along with the partial charges determined
from electronic structure calculations for the peptoids.200, 201 The same dihedral parameters that are
used in the peptide case for the planarity of the amide bond was used here. The OPLS based forcefield has previously been used successfully to model peptoids.202 l-PNMG100 with a chloride
counter anion and c-PNMG100 were each solvated, using the packmol program,203 in a periodic
cubic box of length 100 Å consisting of the same number (11500) of methanol (represented using
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the united atom OPLS force-field)200 molecules in each case. The system was equilibrated for 10
ns, with a 1 fs timestep, in the canonical (NVT) ensemble at a temperature of 300 K using a NoseHoover thermostat. Production runs of 40 ns each were then carried out for each peptoid system.
3.2.10.2 Umbrella sampling (US) simulations
Umbrella sampling along with the weighted histogram analysis method (WHAM) was used
to determine the free energy profile or potential of mean force (PMF) of bringing the center of
mass of one c-PNMG100 monomer to the center of mass of another c-PNMG100 monomer in
methanol solution.204,

205

The simulation box was generated by replicating the previous C-

PNMG100 system along the x-axis. A total of sixteen umbrella sampling windows ranging from an
inter-polymer distance of 50 Å to 22 Å were carried out, each with a ten nanosecond equilibration
run followed by a 40 ns production run. A harmonic force constant of 3.0 kcal/mol was used for
the 22 and 23 Å windows and 2.0 kcal/mol for the remaining windows. All simulations, both
canonical and umbrella sampling, were carried using the LAMMPS package.206
3.3 Results and Discussion
Our group has demonstrated that cyclic bottlebrush polypeptoids can be synthesized via
first NHC-mediated ZROP of NCA monomers and subsequent side chain conjugation with PEG
(Mn= 550 g·mol-1, PEG550). However, NHC is moisture-sensitive and expensive. DBU which is
moisture-stable and commercially available was developed as a candidate of NHC. Because our
previous study has suggested that cyclic polypeptoids can be produced by DBU-mediated ZROP
of R-NCA monomers in a controlled manner, polypeptoid backbones of the cyclic bottlebrushes
for this study were synthesized using DBU as the initiator. Hydrodynamic volume and end-group
structures of cyclic polypeptoids were analyzed before in order to obtain the architectural
information, but the request for further important physical parameters cannot be satisfied. In this
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study SANS analysis was performed on both cyclic bottlebrush polypeptoids and cyclic poly(Nmethyl glycine)s (c-PNMGs) in MeOH to investigate their physical parameters and solution
behaviors. Compared to cyclic polypeptoids with simple side chains, the densely grafted side
chains of cyclic bottlebrush polypeptoids may rigidify the backbone conformation, so quantitative
analysis was conducted to probe the dimensions of cyclic bottlebrush polypeptoids in both dry
state and solution phase by a combination of AFM, TEM, and SANS methods.
3.3.1 Synthesis of cyclic bottlebrush polypeptoids
A series of cyclic random copolypeptoids was synthesized by DBU-mediated ZROP of a
mixture of Pg-NCA monomers and Bu-NCA monomers in THF (Scheme 3.1). The targeted
composition of the resulting poly (N-propargyl glycine)-r-poly (N-butyl glycine)s [P(NPgG-rNBG)s has the molar ratio of Pg segment and Bu segment equal to 6:1, and the targeted repeating
units are 105, 210, 315, and 420. The choice of a random copolypeptoid backbone is based on our
previous observation that the poly(N-propargyl glycine) homopolymers (PNPgG) have strong
tendency to aggregate in solution,75 and the incorporation of Bu segments onto the polypeptoid
backbone spaces out Pg segments, so P(NPgG-r-NBG) copolypeptoids can afford higher PEG
grafting efficiency.
Scheme 3.1. A representative synthetic approach of cyclic P(NPgG-r-NBG)

The percent yield of each random copolypeptoid is from 80% to 90%.1H NMR spectra of
all the random copolymers showed characteristic peaks a, b and c corresponding to the methylene
and methyl protons of the butyl side chains. Characteristic peak h relevant to the alkyne protons
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of the propargyl side chains was also observed (Figure S3.1). End-group analysis using 1H NMR
revealed that the actual compositions of each random copolypeptoid are DBU-P(NBG22-rNPgG118)

[D-P(NBG22-r-NPgG118)],

DBU-P(NBG34-r-NPgG190)

[D-P(NBG34-r-NPgG190)],

DBU-P(NBG73-r-NPgG302) [D-P(NBG73-r-NPgG302)], and DBU-P(NBG91-r-NPgG389) [DP(NBG91-r-NPgG389)], respectively. Among all the random copolypeptoids, the one with targeted
DP= 210 is large enough to be probed by microscopic analysis and short enough to be synthesized
effectively, so another batch of DBU-initiated copolypeptoids (targeted DP= 210) was synthesized
and used as a model sample for atomic force microscopic analysis (AFM) and Kratky plot analysis.
The sample’s actual composition determined by 1H NMR is DBU-P(NBG41-r-NPgG177) [DP(NBG41-r-NPgG177)] which is slightly different from the first batch. The SEC traces of all the
random copolypeptoids have shoulders of varying intensity at low elution time, indicating the
existence of high molecular weight species. We tentatively attribute them to the aggregates of the
random copolypeptoids.75 The poly(N-propargyl glycine)s have strong tendency to aggregate in
solution. Despite of the large aggregates and broad molecular weight distribution, the SEC traces
of random copolypeptoids shift to high molecular weight as the targeted DP increases (Figure S3.2
(A)). The random copolypeptoids were then reacted with N3-terminated PEG550 via Copper (I)mediated alkyne-azido cycloaddition (CuAAC) click chemistry to yield cyclic bottlebrush
polypeptoids with the same repeating units and compositions to their precursors (Scheme 3.2).
The CuAAC click chemistry was performed in DCM at 40 oC for 2 h. Excess PEG550 and
CuBr catalysts were removed by passing the crude reaction solution through a silica-gel packed
mini column to yield the pure cyclic bottlebrush polypeptoids (Percent Yield= 40 to 60 %).
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Scheme 3.2. Synthesis of cyclic bottlebrush polypeptoids via CuAAC click chemistry.

Figure 3.1. A representative 1H NMR spectrum of the cyclic bottlebrush polymer DBU-P(NBG41r-NPgG177)-g-(PEG550)177.
100% grafting efficiency was observed by 1H NMR spectra of all cyclic bottlebrush
polypeptoids based on the disappearance of the alkyne peak at 2.3 ppm and the appearance of the
triazole peak at 8.0 ppm (Figure 3.1). SEC analysis of the model random copolypeptoids [DP(NBG41-r-NPgG177)] and the corresponding bottlebrush polypeptoids [D-P(NBG41-r-NPgG177)g-(PEG550)177] revealed a larger hydrodynamic volume after grafting with PEG550 (Figure 3.2).
These combined results confirmed the successful synthesis of cyclic bottlebrush polypeptoids.
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Figure 3.2. SEC chromatograms of DBU-P(NBG41-r-NPgG177)-g-(PEG550)177 (—) and the DBUP(NBG41-r-NPgG177) precursor (—).
Two linear analogs of each cyclic bottlebrush polypeptoids were synthesized. Linear
analog 1 bottlebrush polypeptoids were prepared by treating the cyclic bottlebrush polypeptoids
with excess amount of AcCl in DCM. Our previous study has shown that cyclic polypeptoids can
be converted to linear counterparts by AcCl-treatment. Representative SEC traces of linear analog
1 polypeptoids are shown in Figure S3.3. Linear analog 2 bottlebrush polypeptoids were prepared
by first ROP of a mixture of Pg-NCA monomers and Bu-NCA monomers using BnNH2 as the
initiator and subsequent side chain conjugation with PEG550. As the role of AcCl is only for endcapping the zwitterionic polypeptoids, the chain length and the composition of cyclic bottlebrush
polypeptoids are not affected by the AcCl-treatment. The same characterizations of cyclic
bottlebrush polypeptoids including 1H NMR and SEC analysis were performed on linear analog 2
bottlebrush polypeptoids. The actual composition of the linear analog 2 determined by end-group
analysis of 1H NMR is Bn-P(NBG33-r-NPgG184)-g-(PEG550)184.
In order to investigate the effects of the brush-like side chains on the properties of cyclic
polypeptoids, a series of cyclic poly (N-methyl glycine)s (D-PNMG), the simplest polypeptoids
with only methyl group as the side chains, was synthesized through DBU-mediated ZROP of Me-
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NCA monomers (Scheme 3.3). The targeted DPs of D-PNMGs are 100, 200, 300, and 400,
respectively. Formation of white precipitates to some extent during the polymerization in
acetonitrile was observed, which might result in further aggregation. Especially for the
polymerization with targeted DP= 400, it took the longest time to reach complete conversion, so
it may have formed the largest aggregates. SEC analysis is consistent with our observations (Figure
S3.2 (B)). It revealed that the SEC traces of D-PNMGs (targeted DP= 100 to 300) are single peaks
with aggregates to some extent. The SEC trace of D-PNMGs (targeted DP= 400) has bi-modal
distribution. The elution times of D-PNMGs are in the right sequence with respect to their targeted
DP values.
Scheme 3.3. Synthesis of D-PNMG and the corresponding linear analog 1.

Table 3.1. The degree of polymerization (DP) values of cyclic polypeptoids
Targeted

Targeted
DP

D-PNMGs
a

c

D-P(NBG-r-NPgG)-g-PEG cyclic
bottlebrush polypeptoids
b

DP

DP (SEC)

100

124

1.01

105

140

1.03

200

188

1.01

210

224

1.15

300

241

1.02

310

375

1.12

400

412

1.01

420

480

1.13

PDI (SEC)

DP (NMR)

a

PDI (SEC)

c

DP was determined by SEC analysis using dn/dc = 0.0991 mL·g-1 in 0.1 LiBr/DMF. b. DP was
determined from end-group analysis using 1H NMR. c. PDI is determined from SEC analysis.
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Actual Mn values of D-PNMGs were obtained by SEC analysis with dn/dc= 0.0991 mL·g1

. Actual DP of each D-PNMG was then calculated based on the Mn of one single repeating unit.

The DP results of both cyclic bottlebrush polypeptoids and cyclic PNMGs are summarized in table
3.1. The linear analog 1 PNMGs were obtained by AcCl-treatment of D-PNMGs (Scheme 3.3).
The representative SEC traces of D-PNMG (targeted DP= 100) and linear analog 1 PNMG can be
found in Figure S3.3. Linear analog 2 PNMGs were prepared by using BnNH2 as the initiator to
polymerize Me-NCA monomers. Targeted DPs of linear analog 2 PNMGs (Bn-PNMG) are 200
and 400, respectively, and SEC analysis revealed that the actual DPs of the Bn-PNMGs are 216
(PDI= 1.01) and 439 (PDI= 1.01), respectively.
3.3.2 AFM analysis
A dilute DCM solution of the cyclic bottlebrush polypeptoids (D-P(NBG41-r-NPgG177)-g(PEG550)177) was dried on a mica substrate under ambient conditions. The bottlebrush
polypeptoids were characterized by taping-mode AFM. Samples of the cyclic bottlebrush
polymers exhibited toroid structures with a relatively uniform distribution across the flat mica
substrate (Figure 3.3). The diameter and width of the rings measured 61 ± 11 nm and 23 ± 9 nm,
respectively (Figure S3.4). The dimensions measured with AFM are larger than the theoretically
estimated diameter (d = 25 nm) and width (l = 9 nm) assuming a fully extended backbone and side
chain structures. The discrepancy can be attributed to the effect of AFM tip-sample convolution.207
For comparison, AFM analyses of the linear analog 1 and the linear analog 2 were also conducted.
Samples of the linear analog 1 bottlebrush polypeptoids (D-P(NBG41-r-NPgG177)-g(PEG550)177- Ac ) exhibited mostly rod-like structures across the mica substrate with the lengths
in the range from 200 nm to 500 nm (Figure 3.4 (A)), which are much longer than the estimated
chain length, indicating aggregates of linear bottlebrush polypeptoids were formed.
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Similarly, samples of the linear analog 2 bottlebrush polypeptoids (Bn-P(NBG33-rNPgG184)-g-(PEG550)184) were observed exclusively as rod-like structures with an average length
and width of 208 ± 100 nm and 41 ± 12 nm, respectively (Figure 3.4 (B)). The theoretically
estimated length and width of the linear analog 2 bottlebrush polypeptoid should be 78 nm and 9
nm, assuming a fully stretched polymer backbone and sidechains. This suggests that the rod
structures are also likely the aggregates of the linear analog 2 bottlebrush polypeptoids. There is
no toroid structures observed in any of the AFM images of the two linear analogs.

Figure 3.3. Toroid-shape structures of cyclic bottlebrush polypeptoids (D-P(NBG41-r-NPgG177)g-(PEG550)177) viewed in representative AFM amplitude images. (A) 4 × 4 µm2, (B) 2.5 × 2.5
µm2.
(A)

(A)

(B)

Figure 3.4. Linear bottlebrush polypeptoids viewed in representative AFM images. (A) DP(NBG41-r-NPgG177)-g-(PEG550)177-Ac, (B) Bn-P(NBG33-r-NPgG184)-g-(PEG550)184.
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3.3.3 Kratky plots
To further verify the cyclic architecture in solution, small angle neutron scattering (SANS)
was conducted on dilute solutions of the cyclic and linear bottlebrush polypeptoid ensembles
respectively in MeOH. The concentration of the solutions was kept in dilute regime (1 wt%) to
ensure that the scattering data reflects the intramolecular conformation without interference from
intermolecular interaction. To obtain the Kratky plots, the incoherent background, determined by
fitting the high Q region of the scattering profile using a power function plus a constant, is
subtracted from the original I(Q) before multiplying the square of momentum transfer (Q). The
cyclic architecture can be identified by the pronounced peak at Q= 0.06 Å-1 in the Kratky plot (red
circle, Figure 3.5), which is attributed to the strong intramolecular correlation of the cyclic
bottlebrush backbones.208 Theoretically, the strong intramolecular correlation can also result from
a dendrimer or a hyperbranched molecular architecture rather than a cyclic molecular architecture,
so it is not possible to identify the cyclic architecture by only analyzing the Kratky plot of the
cyclic bottlebrush polypeptoids. In order to exclude the possibility that the pronounced peak is due
to other molecular architectures with strong intramolecular correlation, the linear analog 1
bottlebrush polypeptoids were analyzed by Kratky plot as well. For the specific zwitterionic cyclic
polypeptoid backbones, it was shown that they can be converted into linear polymers after endgroup treatment with AcCl, and thereby the intramolecular correlation of the linear analog 1
bottlebrush polypeptoids should be much reduced than that of the cyclic precursors. On the other
hand, after end-group treatment, the dendrimer-like polymers or the hyperbranched polymers
should still maintain the original architecture without compromising the intramolecular correlation.
Kratky plot analysis revealed that the peak of the linear analog 1 bottlebrush polypeptoids is lower
than the peak of their precursors (blue circle, Figure 3.5), which is consistent with our assumption
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that the cyclic bottlebrush polypeptoids are present in the solution. The linear analog 2 bottlebrush
polypeptoids have the least pronounced peak in Kratky plot (black circle, Figure 3.5). Considering
that the side chain is PEG with Mn= 550 g·mol-1, the small bump in the Kratky plot of the linear
analog 2 may be attributed to the weak intramolecular correlation of the PEG side chains. The peak
of the linear analog 1 is higher than that of the linear analog 2. This implies an incomplete
architectural conversion from cyclic bottlebrush polypeptoids to the linear analogs after AcCltreatment, which is consistent with the results from our previous architecture study in Chapter 2.
The peak of the linear analog 1 is attributed to the intramolecular correlation of the cyclic
architecture of the residual cyclic bottlebrush polypeptoids and the PEG side chains.
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Figure 3.5. Kratky plots of cyclic bottlebrush polypeptoids [D-P(NBG41-r-NPgG177)-g(PEG550)177] (red circle: ○), the linear analog 1 [D-P(NBG41-r-NPgG177)-g-(PEG550)177-Ac]
(blue circle: ○), the linear analog 2 [Bn-P(NBG33-r-NPgG184)-g-(PEG550)184] (black circle: ○).
3.3.4 Guinier analysis
Model-free Guinier analysis on the SANS profiles was performed for all the samples
including cyclic bottlebrush polypeptoids, the linear analog 1 bottlebrush polypeptoids, the linear
analog 2 bottlebrush polypeptoids, cyclic PNMGs, the linear analog 1 PNMGs, and the linear
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analog 2 PNMGs. Their radii of gyration (Rg) were obtained by Guinier plot analysis, and all
Guinier plots are shown in Figure (S3.5-S3.9). The Q range was selected with the criteria of
RgQmax<1. The size of a cyclic polymer is expected to be smaller than its linear analog having the
same contour length, resulting in a characteristic ratio (Rg,c/Rg,l) in the 0.5 ( condition)- 0.72
range, due to their intrinsic topological difference.209 Hence, it can be expected that Rg of the linear
analog 1 polypeptoids and the linear analog 2 polypeptoids should be larger than the cyclic
polypeptoids. However, in contradiction, the radii of gyration of the cyclic bottlebrush
polypeptoids and the cyclic PNMGs are larger than their respective linear analog 1 polypeptoids
(D-bottlebrush polypeptoid-Acs and D-PNMG-Acs) and linear analog 2 polypeptoids (Bnbottlebrush polypeptoids and Bn-PNMGs) at all the characterized DP values (Figure 3.6). This
suggested that the cyclic polypeptoids may not behave as individually solubilized molecules in
solution and have formed small clusters, resulting in larger effective Rgs relative to their linear
counterparts. As the cyclic polypeptoids contain oppositely charged chain ends, it is anticipated
that the dipole-dipole interaction may provide the driving force for the cluster formation. By
contrast, the linear analog 1 molecules only bear a positively charged chain end with a chloride
counter-ion, and the linear analog 2 molecules have neutral chain ends. The absence of dipoledipole interaction may preclude the cluster formation in solution for the linear polymers.
The effects of brush side chains on the properties of polypeptoids were further studied by
fitting the measured SANS profiles of D-PNMGs and cyclic bottlebrush polypeptoids (both
targeted DP= 100) with the model of cyclic ideal chains,210 to obtain the structural information
such as Kuhn length and the cross sectional radius. Two plots of cyclic PNMG and cyclic
bottlebrush polypeptoid are shown in Figure 3.7, respectively.
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Figure 3.6. Plots of Rg vs. DP for D-PNMGs and their linear analogs (A) and D-bottlebrush
polypeptoids and their linear analogs (B).
In the data fitting, the contour lengths were fixed based on the DP values characterized by
SEC for D-PNMG (DP= 124, contour length= 518.3 Å) and NMR spectroscopy for the cyclic
bottlebrush polypeptoid (DP= 140, contour length= 511 Å). The fitted Kuhn length is 5.9 Å and
the cross sectional radius is 1.5 Å for the D-PNMGs, and 18.7 Å and 9.5 Å for the cyclic
bottlebrush polypeptoids, respectively. The results are consistent with the observation for
bottlebrush polymers that the attachment of brush side chains onto polymer backbones rigidifies
the backbone conformation and largely increases the chain stiffness and cross-sectional radius.
The results suggested that the cyclic bottlebrush polypeptoids may exist in methanol as a cyclic
cylindrical chain with high stiffness. However, it can be seen that for both models, the model
fittings deviate from the experimental data points, indicating that the system is not composed of
cyclic ideal chains. Given the results of Guinier plot analysis of both cyclic polypeptoids and the
linear analogs, the deviations could be due to cluster formation in solution. One can also note that
the model fitting of D-PNMGs has more deviation at low q than the cyclic bottlebrush polypeptoids
does, and this could be due to the solvent quality or large aggregation of molecules.
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(A)

(B)

Figure 3.7. Representative SANS profiles of D-PNMGs (A) and cyclic bottlebrush polypeptoids
(B) (both targeted DP= 100). The black solid line is the data fitting using cyclic Gaussian chain
model.
3.3.5 DLS analysis
Size distributions of cyclic bottlebrush polypeptoids and D-PNMG (both targeted DP= 100)
and their corresponding linear analog 1 polypeptoids were analyzed using dynamic light scattering
(DLS) in MeOH (Figure 3.8). It was revealed that the hydrodynamic radius (Rh) of D-PNMGs in
MeOH is 25.0 ±0.5 Å (PDI= 0.14) and the Rh of the relevant linear analog 1 is 21.9 ±0.1 Å (PDI=
0.12). The Rh of cyclic bottlebrush polypeptoids is 49.7 ±0.3 Å (PDI= 0.11) and the Rh of its linear
analog 1 is 44.1 ± 0.1 Å (PDI= 0.14). Both D-PNMGs and cyclic bottlebrush polypeptoids have
larger sizes than their corresponding linear analog 1 polypeptoids, and the size of cyclic bottlebrush
polypeptoids is much larger than that of D-PNMGs attributed to the incorporation of brush side
chains. Shape factor (ρ= Rg/Rh) is usually used to estimate the shape of polymer chains in solution.
When the theoretical value of ρ is 0.778, it indicates the presence of homogeneous hard spheres.
When the value is between 0.778 and 0.816, it represents the presence of random-coil chains. The
shape of ellipsoids is reflected when the ρ value lies in the range of 0.875 to 0.987.211 The ρ values
of the cyclic polypeptoids and their linear analog 1 polypeptoids were analyzed. It was found that
the ρ value of cyclic bottlebrush polypeptoids is 0.897 and the ρ value of D-PNMGs is 0.956.
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Although the size of cyclic bottlebrush polypeptoids is much larger than D-PNMGs in solution, it
is suggested by their shape factors that both of them may adopt an ellipsoid shape in solution. In
contrast, the ρ values of the linear analog 1 of the cyclic bottlebrush and the linear analog 1 of DPNMGs are 0.576 and 0.594, respectively, indicating that the linear polypeptoids may adopt a
random coil shape in solution. The different shapes in solution for the cyclic polypeptoids and the
corresponding linear analogs could be due to the conformational differences of the polymer
backbones or cluster formation of cyclic polypeptoids.
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Figure 3.8. Size distribution of D-PNMGs (targeted DP= 100) and their linear analog 1 (A) and
cyclic bottlebrush polypeptoids (targeted DP= 100) and their linear analog 1 (B) based on dynamic
light scattering.
3.3.6 Cryo-Transmission electron microscopic results
To verify the formation of small clusters of cyclic polymers, we measured the cyclic
P(NBG-r-NPgG)-g-PEG bottlebrush copolymer (targeted DP= 400) using cryo-TEM. Due to the
resolution limit of cryo-TEM, we selected the largest cyclic bottlebrush polypeptoids for direct
imaging in vitrified methanol. A representative cryo-TEM image is shown in Figure S3.10 (A).
The presence of these small clusters can explain the abnormal variation of the particle sizes (Rg)
in Figure 3.6. The mean size of these small clusters (12.2 ± 2.8 Å) (Figure S3.10 (B)) is in the
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same length scale of a single polymer chain. Thus, their features in SANS profiles cannot be
separated from each other. The measured SANS profile is actually the average of the profiles of
all species including single molecules, dimers, trimers, and oligomers, weighted by their scattering
power. Therefore, it is not surprising that there is a large deviation between the model fitting using
the cyclic Gaussian chain model and the experimental SANS data, as the model only describes the
structure of a single polymer chain. The cluster structures observed in the dilute methanol solution
of the cyclic bottlebrush polypeptoids (targeted DP= 400) are expected to present for those with
lesser DP values and also for the cyclic PNMGs, since they have similar chemical composition
and the SANS measurements show the same trend in the Rg variation for all DP values and both
types of cyclic polypeptoids.
3.3.7 Computational study
In the effort to investigate the driving force for cluster formation, our collaborator
conducted computational study. Given the fact that the peripheral volume due to PEG side chains
cannot effectively restrain the process, the simplest zwitterionic cyclic PNMG (DP= 100) and its
linear counterpart were used for the computational simulation whose results should apply to the
case of cyclic bottlebrush polypeptoids too. Our collaborator simulated the process of dimer
formation for the cyclic polymers using the free energy profile, also called the potential of mean
force (PMF), as a function of the distance of mass centers. Using umbrella sampling, we obtained
the PMF of two cyclic PNMG polymers with DP=100 in methanol solution, as shown in Figure
3.9 (A). At a separation of about 24 Å there is a free energy minimum of around 0.5 kcal/mol,
indicating an attractive region. However, the statistical error of the overall PMF is comparable to
the energy barrier, and the depth of the relative free energy is of the order of kBT, so both the
formation and dissociation of dimers can rapidly occur, indicating an equilibrium of the reversible
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process. In terms of the PFM simulation, monomers, dimers, and oligomers should exist in solution,
which is consistent with our experimental results (Figure S3.10 (A)). On the other hand, the PMF
of the linear counterpart suggests that the linear polymer is unlikely to aggregate in dilute solution
(Figure 3.9 (B)).

(A)
a)

(B)
b)

Figure 3.9. The free energy profile as a function of the mass center separation between (A) two cPNMG polymer chains (DP= 100) and (B) two l-PNMG polymer chains (DP=100).
We defined one building block of the cyclic PNMG backbone as “coordinated” to solvent
molecules if there is at least one oxygen atom of methanol is located within the first solvation layer
of the carbonyl oxygen of the building block. The percentage of the coordinated building blocks
in the whole polymer chain indicates the level of solvation of the cyclic PNMG chain. Then the
coordination percentage as a function of distance of mass centers during dimerization was
simulated, as shown in Figure 3.10. The coordination percentage gradually decreases as the two
polymers are approaching to each other because solvent molecules keep getting excluded from the
first solvation shell. A plateau is reached when their mass centers get into the range from 25 Å to
35 Å, where the solvent molecules located in the first solvation shells of the two polymers are
rearranged in order to minimize the free energy. Until the distance of their mass centers reaches
r= 25 Å, the first solvation shell between the two PNMG polymers starts to get fully excluded and
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the coordination percentage reaches its minimum value. It is worth noting that even at the shortest
mass center distance, more than half of the building blocks in the dimerized PNMGs are still
exposed to the surrounding solvent molecules, so it is reasonable that the coordination percentage
is reducing from 80.5% to 67.5%. This study illustrated the process of dimerization as a result of
solvophobic interaction.

Figure 3.10. The percentage of O atoms on the polymer backbones that are coordinated to methanol
as a function of mass center distance of the two c-PNMG monomers (DP= 100).
It has been demonstrated by the coordination percentage simulation that the solvophobic
interaction is one attractive force for cluster formation. It is also conceivable that the dipole-dipole
interaction plays a role during dimerization according to our pervious study that DBU-initiated
polypeptoids are zwitterions. To further study the mechanism of dimerization and the interplay
between these forces, we calculated the probability distribution of dipole-dipole interaction as a
function of dipole-dipole distance at different distances of mass centers between the two PNMG
polymers, presented in Figure 3.11. It was revealed by the study that as the two polymers are
approaching to each other from 36 Å to 28 Å, the probability distribution of dipole-dipole
interaction is shifting to the smaller dipole-dipole distance, indicating the orientation of the dipoles
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towards each other. Dipole-dipole interaction is suggested the dominant driving force for this
region. As the two polymers are approaching even closer to 24 Å, the orientations of the dipoles
are rotating opposite to each, evidenced by the probability distribution shifting to a longer dipoledipole distance. Solvophobic interaction is suggested the dominant driving force for this region.
Although solvophobic interaction tends to drive the two cyclic polymers to get closer, the dipoles
have strong preference to be solvated, which counteracts the dominant driving force and prevents
the formation of larger aggregates.

Figure 3.11. Dipole-dipole distance distribution as a function of the distance between mass centers
of the two c-PNMG monomers (DP= 100). The curves are normalized to have unit area.
3.4 Conclusions
Cyclic bottlebrush polypeptoids with various compositions were synthesized by first DBUmediated ZROP of Pg-NCA monomers and Bu-NCA monomers and subsequent conjugation with
PEG550 chains. AFM analysis revealed toroid structures of cyclic bottlebrush polypeptoids in dry
state which are different from the rod-like structures formed by the linear analogs. Kratky plot
analysis further suggested that the strong intramolecular correlation of the cyclic bottlebrush
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polypeptoids is due to the cyclic backbone conformation in solution. Guinier plot analysis revealed
that the Rg values of both cyclic bottlebrush polypeptoids and cyclic PNMGs are larger than their
corresponding linear analog 1 polypeptoids, indicating cluster formation of cyclic polypeptoids in
MeOH. Clusters were observed by cryo-TEM images of cyclic bottlebrush polypeptoids (targeted
DP= 420). DLS analysis showed that Rhs of both cyclic bottlebrush polypeptoids (targeted DP=
100) and cyclic PNMGs (targeted DP= 100) are larger than their linear analog 1 polypeptoids,
which is consistent with Guinier plot analysis. The shape factor indicates that cyclic polypeptoid
backbones may adopt an ellipsoid shape in solution. Computational study revealed that the cluster
formation is driven by both dipole-dipole interaction and solvophobic interaction but counteracted
by dipole solvation, with different interaction dominating at different inter-polymer distances. The
solution aggregation behaviors of zwitterionic cyclic polypeptoids both with and without long side
chains were systematically studied for the first time. The results indicate that the aggregation
behaviors of the zwitterionic cyclic polypeptoids are not affected by the backbone chain length
(targeted DP= 100 to 400) or the side chains (PEG, Mn= 550 gmol-1) but strongly dependent on
the ion pairs at the polymer chain ends.
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3.5 Supplementary Data

Figure S3.1. A representative 1H NMR spectrum of DBU-P(NBG41-r-NPgG177) obtained by DBUmediated polymerization of Bu-NCA and Pg-NCA in THF at 50°C.
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Figure S3.2. Normalized SEC traces of D-P(NPgG-r-NBG) with varying compositions (A) and DPNMG with varying compositions (B).
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Figure S3.3. Representative normalized SEC traces of c-bottlebrush polypeptoids with targeted
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(B)

Figure S3.4. (A) A representative AFM image of the cyclic bottlebrush polymer DBU-P(NBG41r-NPgG177)-g-(PEG550)177 and (B) cross-section of the toroid-shape structure under the white line
in (A).

- 75 -

1.0

DBU-Bottlebrush 100
Rg= 44.66 0.26 Å

0.3

DBU-Bottlebrush 200
Rg= 69.13 ± 0.75 Å

0.8

ln(I(Q))

ln(I(Q))

0.0
-0.3
-0.6

0.6

0.4

-0.9
0.0000

0.0003

0.0006
2

0.0009

0.2

0.0012

0.00004 0.00008 0.00012 0.00016 0.00020 0.00024
2

-2

Q (Å )

1.2

1.4

DBU-Bottlebrush 300
Rg= 82.67 ± 1.62 Å

DBU-Bottlebrush 400
Rg= 91.77 ± 1.42 Å

1.2

ln(I(Q))

ln(I(Q))

1.0

0.8

0.6

0.4

-2

Q (Å )

1.0

0.8

0.00006

0.00012
2

0.6

0.00018

0.00004

0.00008

0.00012
2

0.00016

0.00020

-2

Q (Å )

-2

Q (Å )
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Figure S3.6. Guinier plots of linear analog 1 bottlebrush polypeptoids and linear analog 2
bottlebrush polypeptoids with varying compositions.
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Figure S3.7. Guinier plots of DBU-PNMGs with varying chain lengths.
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Figure S3.10. A representative cryo-TEM image of cyclic P(NBG-r-NPgG)-g-PEG bottlebrush
copolymer (targeted DP= 400) in vitrified methanol. Dimers, trimers, and oligomers are indicated
by the red arrows. (B) The histogram analysis of the aggregated particle sizes seen in the cryoTEM micrograph. (Note: a total of 124 measurements of aggregated particle size are used in the
analysis). The mean diameter of the aggregated particle is 12.2 ± 2.8 nm, consistent with the
particle dimension determined from the SANS analysis (Figure 3.6 (B)).
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Chapter 4. Synthesis and Characterization of Cleavable Core-Crosslinked
Micelles Based on Amphiphilic Block Copolypeptoids as Smart Drug Carriers
4.1 Introduction
Polymeric micelles have been widely investigated as nanocarriers for drug delivery
application due to their ability to enhance the water solubility of hydrophobic drugs, protect drugs
against degrading enzymes, overcome multi-drug resistance (MRD),96, 97 enhance accumulation of
drugs selectively at the diseased sites and increase circulation time of drugs in human body. 98-100
Conventional polymeric micelles formed by self-assembly of amphiphilic polymers via
hydrophobic interaction may spontaneously dissociate upon dilution, resulting in pre-leakage
during drug delivery. To enhance the in vivo stability of the polymeric micelles, different strategies
including chemical crosslinking of the micellar core or shell have been developed. The
permanently cross-linked micelles, which cannot be disintegrated, may be difficult to remove
through renal clearance.105 In order to address the dilemma, stimuli-responsive core-crosslinked
micelles (CCLMs) which can maintain their structures upon dilution and undergo dissociation in
response to environmental cues, have been investigated in the last decade.106, 107
Nanocarriers based on polymeric micelles that are responsive to light,108-111
temperature,112-114 enzymes, pH, and a reductive environment have been developed for controlled
drug delivery applications. In particular, redox responsive polymeric micelles have been
judiciously designed by incorporating redox responsive units (e.g., disulfide, diselenide119, thioether120 and acrylboronic ester121) either onto the polymer backbone, 122, 123 side chains124, 125 or as
cross-linkers.126-128
*This chapter previously appeared as [Ang Li and Donghui Zhang, Synthesis and Characterization
of Cleavable Core-Cross-Linked Micelles Based on Amphiphilic Block Copolypeptoids as Smart
Drug Carriers. Biomacromolecules, 2016, 17, 852–861.] It is reprinted by permission of American
Chemical Society.
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These micelles were shown to respond to oxidants (e.g., H2O2) or reductants (e.g., GSH)
that are naturally present in the cellular environment by undergoing morphological changes. For
in vivo drug delivery application, it is desirable that the building blocks of the nanocarriers are
minimally cytotoxic and backbone degradable in vivo, allowing for systematic clearance of the
materials. As a result, increasing attention has been focused on redox responsive micelles
containing at least one hydrolytically degradable block such as polypeptide-b-poly(ethylene
glycol) (PEG),126 poly(ε-caprolactone)-b-PEG,128 polylactide-b-PEG,137 and poly(-hydroxy
acid)-b-PEG.127, 138. While poly (ethylene glycol) (PEG) is the most widely investigated polymer
for various drug delivery systems with several PEGylated micellar or liposomal formulation in
advanced clinical studies,139-142 studies have shown that PEG can trigger complement activation,143,
144

and PEGylated liposomes can be cleared rapidly upon repeated injections.145-148 There is a clear

and continued need to develop and investigate new micellar materials for drug delivery application.
Polypeptoids composed of poly (N-substituted glycine) backbones are a class of
peptidomimetic polymers. Due to N-substitution, polypeptoids lack chirality and hydrogen
bonding along the main chain, in contrast to polypeptides. This results in polypeptoids having
enhanced proteolytic stability,157, 212, 213 cell permeability,214 thermal processability15, 16, 69 and
tunable conformation7, 158, 215 by controlling the side chain structures, relative to polypeptides.
Polypeptoids bearing neutral side groups have been found to be minimally cytotoxic 1, 19, 88, 151, 216
and can degrade in oxidative conditions that mimic inflammation in vivo,165 suggesting their
potential of systematic clearance desired for in vivo applications. Amphiphilic block copolymers
comprised of hydrophilic poly(N-methyl glycine) (a.k.a. polysarcosine) in the forms of micelles,
vesicles, nanoparticles or microparticles have been investigated as drug carriers.150, 153, 164, 217-220 In
some cases, pH responsive drug release has been demonstrated.221, 222 Recent advances in the
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synthetic method development have enabled the access to a wide range of well-defined
polypeptoids with diverse side chain structures.14,

26, 69, 75, 84, 223

Many of the fundamental

physicochemical properties of polypeptoids have been benchmarked,224 which set the stage for
further development of functional polypeptoids for advanced applications.28, 225
In this work, we reported the synthesis and characterization of a new class of redox-active
core-crosslinked polymeric micelles based on amphiphilic polypeptoid block copolymers. The
polymers were synthesized by primary amine-initiated controlled polymerization of N-substituted
N-carboxyanhydrides (R-NCAs). The solution self-assembly of block copolypeptoids were studied
and the resultant polymeric micelles were core-crosslinked with disulfide linkages to confer redox
responsive characteristics. The micellization and redox-triggered micellar dissociation have been
characterized by a combination of analytical methods. Encapsulation of Doxorubicin (DOX), a
blockbuster anti-cancer drug, with the micelles and the redox-triggered drug release behavior have
also been investigated.
4.2 Materials and Methods
4.2.1 General considerations
DL-Dithiothreitol (DTT) (≥98%) and 1-anilinonaphthalene-8-sulfonic acid (1,8-ANS)
(≥97%) were obtained from Sigma-Aldrich and used as received. Doxorubicin hydrochloride
(DOX∙HCl) (>99%) was purchased from LC Laboratories and used as received. All solvents used
in this study were purchased from Sigma-Aldrich. Tetrahydrofuran (THF) was purified by passing
through alumina columns under argon. The N-ethyl NCA (Et-NCA), N-propargyl NCA (Pg-NCA)
and N-decyl NCA (De-NCA) were synthesized by adapting literature procedures.69, 75, 165 1-Azido2-[(2-azidoethyl)disulfanyl]ethane cross-linker (CL1) and the 1,4-diazidobutane cross-linker (CL2)
were synthesized by following a published procedure.138
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4.2.2 Instrumentation
The 1H NMR spectra were recorded on Bruker AV 400 and AV 500 spectrometers and the
peaks were referenced in parts per million (ppm) relative to proton impurities of CDCl3 or CD2Cl2,
respectively. Size-exclusion chromatograms (SEC) were recorded on an Agilent 1200 system
(Agilent 1200 series degasser, isocratic pump and auto sampler) equipped with three Phenomenex
5 μm, 300 x 7.8 mm columns [100 Å, 1000 Å and Linear (2)], Wyatt DAWN EOS multiangle light
scattering (MALS) detector (GaAs 30 mW laser at λ= 690 nm) and Wyatt Optilab rEX differential
refractive index (DRI) detector with a 690 nm light source. DMF containing 0.1 M LiBr was used
as the eluent at a flow rate of 0.5 mL∙min-1. The column temperature and the detector temperature
were both kept at 25 °C. All data analyses were performed using Wyatt Astra V 6.0 software. The
polymer molecular weight (Mn) and the molecular weight distribution (PDI) were obtained by
conventional SEC analyses with a standard calibration curve of polystyrene. High molecular
weight (MW) shoulders were included in the peak analysis whenever they were present. The
standard calibration curve was constructed with polystyrene standards (EasiCal PS-1 MW = 580
g∙mol-1 to 7500 kg∙mol-1,Varian) using Astra's column calibration template. Dynamic light
scattering (DLS) was conducted on a Malvern Zetasizer Nano-ZS instrument and analyzed by the
Zetasizer software version 7.03 using the cumulant method. Micelle samples were filtered through
hydrophilic filters (pore size = 0.2 µm) before DLS measurement. Z-average diameters and the
averaged size distributions were obtained from triplicate measurements. The UV-Vis absorption
spectra were collected on HP 845x and processed on the software of HP 845x UV-Vis spectrometer.
Fluorescence measurements were completed with the Perkin Elmer luminescence spectrometer LS
50B and the spectra were processed by the software of FL winlab. Transmission electron
microscopic (TEM) samples were prepared by firstly drop-casting micellar solution onto a copper
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grid, air-drying the solution at room temperature, and then negatively staining the sample with 1
wt% aqueous solution of uranyl acetate (UA). TEM analysis was conducted with JEM-1400 TEM
at 80 kV.
4.2.3 Representative synthetic procedure for amphiphilic block copolypeptoids [PNEG-bP(NPgG-r-NDG)]
N-Ethyl NCA (Et-NCA) (300 mg, 2.33 mmol) was dissolved in anhydrous THF (2.2 mL)
to which a stock solution of benzylamine in THF (122 μL, 11.6 μmol, 95.2 mM) was added inside
a glovebox under nitrogen atmosphere. The reaction mixture was allowed to react at 50 °C for 48
h to reach a complete conversion, as determined by 1H NMR spectroscopic analysis of a reaction
aliquot. N-propargyl NCA (Pg-NCA) (24 mg, 0.174 mmol) and N-decyl NCA (De-NCA) (42 mg,
0.174 mmol) were added to the above THF solution containing poly(N-ethyl glycine) polymer
(PNEG). The reaction mixture was heated at 50 °C for additional 24 h to reach complete monomer
conversion. An excess of hexane was added to the reaction mixture to precipitate the resulting
block copolypeptoid polymer. The suspension was filtered through a Durapore membrane filter
(0.45 μm, 47 mm, PVDF) and the precipitate were collected and dried under vacuum to afford a
white solid (216 mg, 91%). 1H NMR spectrum of poly(N-ethyl glycine)-b-poly[(N-propargyl
glycine)-r-(N-decyl glycine)]  (in CD2Cl2, ppm): 1.07 (EtCH3CH2), 3.39 (EtCH3CH2-), 4.00 (EtCH2NCO-),

2.38

(PgCHCCH2-),

4.28

(PgCHCCH2-),

4.24

(Pg–CH2NCO-),

0.87

(DeCH3(CH2)7CH2CH2-), 1.26 (DeCH3(CH2)7CH2CH2-), 1.50 (DeCH3(CH2)7CH2CH2-), 3.39
(DeCH3(CH2)7CH2CH2-), 4.00 (De–CH2NCO-).
4.2.4 Determination of critical micelle concentration (CMC)
A stock solution of PNEG-b-P(NPgG-r-NDG) (0.2 mM) and 1,8-ANS (80 μM) was
prepared by dissolving the PNEG-b-P(NPgG-r-NDG) diblock copolypeptoid (12 mg) in an
aqueous solution of 1,8-ANS (3 mL, 80 μM). Aqueous solutions of different PNEG-b-P(NPgG-r- 83 -

NDG) concentration (0.14-22.7 μM) and a constant 1,8-ANS concentration (80 μM) were then
prepared by transferring varying volumes of the stock solution (3-625 μL) into a 5 mL volumetric
flask and diluted with the 1,8-ANS aqueous solution (80 μM). The fluorescence spectra were
collected from 400-600 nm at ex = 370 nm excitation wavelength. The fluorescence maximum,
which shifts to lower wavelength in the range of 452-487 nm with increasing polymer
concentration, was plotted against the polymer concentration. The concentration at the inflection
point is defined as the critical micellation concentration.226
4.2.5 Preparation of core-crosslinked micelles (CCLMs) and irreversibly core-crosslinked micelles
(ICCLMs) based on the amphiphilic block copolypeptoids.
A stock solution of the PNEG-b-P(NPgG-r-NDG) block copolypeptoid in DMF [660 μL,
14 µmol (propargyl group)] was mixed with a stock solution containing the 1-azido-2-[(2azidoethyl)disulfanyl]ethane cross-linker (CL1) in DMF (40 μL, 5 µmol, ) at room temperature.
Distilled water (20 mL) was then added into the above solution dropwise with vigorous stirring
for 24 h at room temperature. Aqueous solutions of CuCl2 (50 μL, 3.5 µmol,) and sodium ascorbate
(74 μL, 3.5 µmol) were then added into the above solution and stirred for an additional 24 h at
room temperature. The mixture was transferred to a dialysis bag (MWCO = 3,500 Da) and dialyzed
against deionized water for 36 h. The core-crosslinked micelles were obtained by lyophilization as
a white solid (18 mg, 90%). The ICCLMs were prepared by the same procedure except for using
the 1,4-diazidobutane as the crosslinker (CL2).
4.2.6 DTT-triggered CCLM dissociation.
An aqueous solution of CCLMs (0.9 mg∙mL-1, 8 mL) was purged by bubbling nitrogen
through it for 15 min followed by addition of DTT (12.3 mg, 80 mmol). The reaction mixture was
stirred for 36 h at room temperature and dried with a rotary evaporator. The resulting solid was
dissolved in DCM and precipitated out by addition of an excess diethyl ether. Subsequent
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centrifugation and filtration yielded a white solid (6.5 mg, 90%) which was subjected to further
analysis by SEC, DLS and 1H NMR methods.
4.2.7 DTT-triggered fluorophore release studies
1,8-ANS-loaded CCLMs was obtained by using 1,8-ANS aqueous solution (80 μM) and
following the same procedure as that for the preparation of the blank CCLMs. After 1,8-ANSloaded CCLMs were obtained, the solution was diluted below the CMC (0.05 mg/mL) by PBS
buffer solution and allowed to reach equilibrium for overnight. Various amount of DTT was then
added into the 1,8-ANS-loaded CCLMs solution (3 mL) to have the DTT concentration in the
0.045 μM-10 mM range. (Note: this concentration range approximately corresponds to 1 to more
than 100 folds of the –S-S- content in the micellar solution by assuming 80% propargyl groups in
the polymer micelles are crosslinked by disulfide linkages). The fluorescence intensity of the
solution was monitored by the luminescence spectrometer in a time-driven mode.
4.2.8 Representative procedure of drug encapsulation
PNEG-b-P(NPgG-r-NDG) (10 mg, 6.8 μmol (propargyl group)) and CL1 (0.55 mg, 2.7
μmol) were dissolved in minimum DMF (50-150 μL). A THF solution of triethylamine (TEA) (10
μL, 5.2 μmol) was added into an aqueous solution of the DOX∙HCl salt (10 mL, 3.2 mg, 5.5μmol)
and stirred at room temperature for 1-2 h. The mixture was then added to the DMF solution
containing the block copolypeptoid and the CL1 with vigorous stirring for 24 h, to which two
aqueous solutions of CuCl2 (25 μL, 1.7 μmol) and sodium ascorbate (37μL, 1.7 μmol) were then
added. After stirring for an additional 24 h, the solution mixture was centrifuged first to remove
any precipitated DOX and dialyzed against DI water for another 4 d to remove any nonencapsulated and soluble DOX in solution. Subsequent lyophilization yielded the DOX-loaded
CCLMs as a red solid (9.6 mg, 87%).
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4.2.9 DLC and DLE measurements
A DMF solution of DOX-loaded CCLMs (0.3 mg∙mL-1) was prepared by dissolving DOXloaded CCLMs (3 mg) in DMF (10 mL) at room temperature. The encapsulated DOX
concentration and the mass of the DOX in the CCLMs were determined by measuring the UV-Vis
absorption of the solution at λ= 480 nm and comparing it to a standard curve that correlates the
absorption and the DOX concentration in DMF. Drug loading capacity (DLC) and drug loading
efficiency (DLE) were obtained by using equation 1 and 2. The averages of DLC and DLE were
obtained based on triplicate experiments.
DLC% =

Encapsulated DOX Concentration
× 100%
CCLM Concentration

eq. 1

DLE% =

Mass of Encapsulated DOX
× 100%
Mass of Initial Loaded DOX

eq. 2

4.2.10 In vitro drug release study
DOX-loaded CCLMs (0.18 mg) were dissolved in PBS buffer (5 mL) containing DTT (10
mM). The solution was then placed into a dialysis bag (MWCO = 3,000 Da) and dialyzed against
the PBS buffer containing DTT (20 mL, 10 mM) at 37 °C in the dark. Aliquots of the buffer
solution (5 mL each time) outside the dialysis bag were collected every few hours. The buffer
solution outside the dialysis bag was then replenished with the same amount of fresh PBS buffer
containing DTT. The collected aliquots were then freeze-dried, re-dissolved in DMF (1 mL) and
filtered through a syringe filter (pore size=0.2 μm). Fluorescence excitation intensity of the
obtained DMF solutions was measured (λem= 560 nm) and converted into DOX concentration
using a standard curve that correlates the fluorescence intensity and the DOX concentration in
DMF. Drug release studies of DOX-loaded CCLMs and DOX-loaded non-crosslinked micelles
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(NCLMs) without DTT were conducted by following the same procedure. The average of
cumulative drug release percentage was obtained based on triplicate experiments.
4.2.11 Cell viability study
Human hepatoblastoma cells (HepG2) were plated in a 96-well plate (10000 cell/well)
using MEMS medium and then incubated in an incubator containing 5% CO2 at 37 °C for 24 h.
Freeze-dried CCLMs and ICCLMs were re-dissolved in the MEMS medium (1 mg/mL),
respectively. They were filtered through a sterile filter (pore size = 0.2 μm), diluted to different
concentrations, added into cells, and then incubated with HepG2 cells in the incubator for another
48 h. Cell cytotoxicity was measured using Promega’s CellTiter 96® Non-Radioactive Cell
Proliferation Assay Kit with the manufacture’s protocol. Cell viability was obtained by comparing
the absorption of each well (λ= 570 nm) to a positive control, which contained only HepG2 cells.
Each experimental group was repeated twice on two different days with 4 trials for each run.
4.2.12 Tumor cell inhibition study
Inhibition of tumor cell growth and proliferation in the presence of DOX or DOX-loaded
micelles was investigated by a similar procedure as that for the cell viability study. Briefly, freezedried DOX-loaded CCLMs and DOX-loaded ICCLMs, and free DOX∙HCl were dissolved in
MEMS medium respectively at various initial DOX concentrations (0.1- 40 μg/mL). The solutions
were filtered through a sterile syringe filter (pore size = 0.2 μm) and then added into HepG2 cells
(a perpetual cell line consisting of human liver carcinoma), which had already been incubated in
an incubator containing 5% CO2 at 37 °C for 24 h. Cell viability was quantified after another 48hour incubation using Promega’s CellTiter 96® Non-Radioactive Cell Proliferation Assay Kit with
the manufacture’s protocol. Cell viability was obtained by comparing the absorption of each well
(λ= 570 nm) to a positive control, which contained only HepG2 cells. The cell inhibition is
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quantitatively defined as the percentage of cell death relative to the positive control (i.e., HepG2
cells only), thus cell inhibition=1- cell viability. Time-dependent tumor cell inhibition study was
conducted by the same procedure except that a constant initial DOX concentration (40 µg·ml -1)
was used in the culturing of the HepG2 cells with the free DOX∙HCl, the DOX-loaded CCLMs
and DOX-loaded ICCLMs for 12 to 72 h. Each experimental group was repeated twice on two
different days with 4 trials for each run.
4.3 Results and Discussion
Scheme 4.1. Synthesis of amphiphilic block copolypeptoids.

We have investigated the synthesis of amphiphilic diblock copolypeptoids consisting of a
hydrophilic poly(N-ethyl glycine) (PNEG) block and a poly[(N-propargyl glycine)-ran-(N-decyl
glycine)] [P(NPgG-r-NDG)] hydrophobic block. Previous studies have shown that PNEG
homopolymer is readily soluble in water and a variety of organic solvents; both the poly(N-decyl
glycine) (PNDG) and the poly(N-propargyl glycine) (PNPgG) homopolymers are hydrophobic and
insoluble in water. As a result, we expect these amphiphilic diblock copolypeptoids to readily
undergo micellization in aqueous solution. The presence of propargyl side groups in the
hydrophobic blocks will allow for further functionalization or crosslinking post polymerization.
Specifically, the block copolypeptoids with a targeted 230 total degree of polymerizations (DP)
and varying composition were synthesized by sequential ring-opening polymerization of Et-NCA
(M1) and then Pg-NCA (M2) and De-NCA (M3) together using benzyl amine initiators in varying
initial monomers to initiator ratios in 50 °C THF. Each step of the polymerization was allowed to
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reach complete conversion and the final block copolymers were isolated by precipitation into
hexane and filtration and drying under vacuum.

Figure 4.1. Representative 1H NMR spectrum of PNEG204-b-P(NPgG13-r-NDG15) polymer in
CD2Cl2 (Entry 1, Table 4.1)
1

H NMR spectroscopic analysis of the resulting polymers confirms the formation of the

PNEG-b-P(NPgG-r-NDG) block copolypeptoids abbreviated as EPgD (Figure 4.1). The polymer
compositions (Table 4.1) were also determined by integrating the methyl protons of N-decyl
glycine (D) segment at 0.87 ppm, propargyl proton of N-propargyl glycine (Pg) segments at 2.38
ppm and the methylene protons due to both N-propargyl glycine and N-ethyl glycine (E) segments
at 3.39 ppm in relative to the benzyl end-group protons at 7.29 ppm in 1H NMR spectra. All
polymers exhibit approximately the same molecular weight in 20.0- 22.6 kg∙mol-1 range.
Size-exclusion chromatographic (SEC) analysis of the polymers (in DMF/0.1 M LiBr
solvent) revealed bimodal peaks with narrow molecular weight distribution (PDI< 1.10) (Figure
S4.1). The minor shoulders present in several samples are tentatively attributed to the polymer
aggregation. Despite the polymers have comparable molecular weights (Mn) as determined by 1H
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NMR analysis, they elute out the SEC column at different elution volumes, indicating that the E,
Pg and D segments of the block copolypeptoids are solvated to varying extent in the DMF/0.1 M
LiBr. This is consistent with our early observation of the relative solubility of the corresponding
PNDG, PNPgG and PNEG homopolymers. In DMF/0.1 M LiBr at room temperature, PNDGs
were found to have negligible solubility,69 whereas PNPgGs readily dissolve albeit with a
significant level of aggregates present75 and PNEGs are highly soluble without any notable
aggregation in the 5-10 mg/mL polymer concentration range typically used for SEC analysis.
Table 4.1. PNEG-b-P(NPgG-r-NDG) block copolypeptoid composition, Mn/PDI, critical
micellar concentration (CMC) and micellar sizes
Entry

[M1]0:[M2]
0:[M3]0:[I]0

Polymer
composition

Mn
(NMR)
b (kDa)

Mn
(SEC) c
(kDa)

CMC d
(µg∙mL-1)

Diameter e
(nm)

PDI e
(DLS)

a

b

1

200:15:15:1

E204Pg13D15

21.6

36.8

113(24)

60.1 (0.9)

0.19

2

185:30:15:1

E176Pg34D16

21.4

40.1

133(44)

25.5 (0.4)

0.28

3

155:60:15:1

E144Pg62D18

21.8

40.8

123(25)

N/A f

N/A f

4

185:15:30:1

E155Pg13D28

20.0

35.5

91(16)

N/A f

N/A f

5

155:15:60:1

E134Pg15D49

22.6

30.3

93(18)

71.1 (0.9)

0.25

a.

The initial monomer to initiator ratio; b. determined by 1H NMR spectroscopy; c. determined by
SEC using polystyrene standards (PDI of all entries < 1.10); d. determined by fluorescence
spectroscopy; error bars are given in the parenthesis; e. Z-average diameter and polydispersity
determined by DLS measurements; error bars are given in the parenthesis; f. multi-modal particle
size distributions were observed for these samples by DLS analysis.
All polypeptoid block copolymers are readily dissolved in water at 1 mgmL-1 polymer
concentration. To characterize the critical micellar concentration (CMC), a series of aqueous
solutions containing a constant concentration of 1-anilinonaphthalene-8-sulfonic acid (1,8-ANS)
and varying concentrations of polypeptoids were prepared and measured by fluorescence
spectroscopy in the 400-600 nm range with an excitation at = 370 nm (Figure 4.2). 1,8-ANS is a
fluorophore that exhibits high fluorescence intensity in a hydrophobic environment but low
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fluorescence intensity in a hydrophilic environment.226 Plot of fluorescence maximum versus
concentration revealed an inflection point where the fluorescence intensity increases sharply. The
polymer concentration at the inflection point is defined as the CMC. The CMCs of all PNEG-bP(NPgG-r-NDG) block copolypeptoids with varying compositions are not significantly different
in the 91-133 µg∙mL-1range, considering the error bars of the measured CMCs (Table 4.1).
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Figure 4.2. (A) Representative fluorescence spectra of 1,8-ANS (ex =370 nm) in the aqueous
solution of E204Pg13D15 at varying concentrations; (B) a representative semi-log plot of the maximum
fluorescence intensity (em = 452- 487 nm) versus polymer concentrations.
The micellar size was characterized by dynamic light scattering (DLS) measurements of
dilute aqueous solutions (0.5 mg∙mL-1) containing the amphiphilic block copolypeptoids. DLS
analysis revealed mono-modal particle size distributions for the E204Pg13D15, E176Pg34D16 and
E134Pg15D49 samples with moderate PDIs (0.19, 0.28 and 0.25 respectively) (Entry 1, 2 and 5,
Table 4.1). The Z-average diameters of the particles are 25.5 ± 0.4, 60.1 ± 0.9 and 71.1 ± 0.9 nm
respectively for these three polymer samples (E176Pg34D16, E204Pg13D15 and E134Pg15D49),
consistent with the formation of micelles. By contrast, samples E144Pg62D18 and E155Pg13D28 (Entry
3 and 4, Table 4.1) appear to form less defined aggregates, evidenced by multi-modal particle size
distributions in DLS. Further experiments are required to fully understand the relationship between
the polymer composition and micellar morphology and size distribution.
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As the E204Pg13D15 sample (Entry 1, Table 4.1) form relatively well-defined spherical
micelles with moderate size distribution (PDI=0.19), it is used as the model system for the
subsequent investigation of core-crosslinking of the micelles, stimuli-responsive dissociation, drug
loading/release behavior and the cytotoxicity studies. Crosslinking of the E204Pg13D15 micellar core
was conducted with diazide crosslinkers by CuAAC chemistry in the presence of CuCl2 and
sodium ascorbate catalyst in water with a small amount of DMF (3.4 vol.%) which was used to
facilitate the initial dissolution of the polymer. Two different diazide crosslinkers [i.e., azido-2[(2-azidoethyl) disulfanyl] ethane (CL1) and 1,4-diazidobutane (CL2)] were examined to produce
reversible core-crosslinked micelles (CCLMs) bearing disulfide cross-linkages in the core and
irreversible crosslinked micelles (ICCLMs). The resulting core-crosslinked micelles were purified
by dialysis against deionized water for 36 h and were further characterized by a combination of 1H
NMR, SEC and DLS analysis. 1H NMR analysis of the CCLMs in CD2Cl2, a non-selective solvent
for both the hydrophilic and hydrophobic blocks of the block copolypeptoid (E204Pg13D15) revealed
the decreased intensity of decyl protons at 1.25 ppm and the disappearance of the characteristic
propargyl proton at 2.38 ppm as compared to the 1H NMR spectrum of the E204Pg13D15 unimers
(Figure S4.2). In addition, the triazole protons that typically appear at ~8 ppm after CuAAC
chemistry are also absent. These results are consistent with the successful crosslinking of the
E204Pg13D15 micellar core by CuAAC chemistry, resulting in reduced solvation of the hydrophobic
core segments where the decyl and triazole groups reside. SEC analysis of the CCLMs in 0.1M
LiBr/DMF (a non-selective solvent for the E204Pg13D15 polymer) revealed a prominent monomodal peak at the low elution volume (18.4 mL) that has a much larger hydrodynamic size than
the constituent E204Pg13D15 unimers (Figure 4.3 (A)), indicating the formation of stabilized
micelles. Two other small peaks at higher elution volumes were also observed in the SEC elugram
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of the CCLMs and overlapped with the elugram peak for the E204Pg13D15 unimers. They are
attributed to the E204Pg13D15 unimers and their small aggregates due to the incomplete corecrosslinking reaction (Figure 4.3 (A)). DLS analysis of the CCLMs in water (0.5 mg∙mL-1)
revealed that the micelles maintain a mono-modal size distribution and the hydrodynamic diameter
is notably decreased to 42.4 ±0.8 nm (PDI = 0.19) relative to the non-crosslinked micelle (NCLM)
precursors (d = 60.1 ± 0.9 nm, PDI = 0.19) in water (Figure 4.3 (B)). In addition, the CCLMs
exhibit very good micellar stability by maintaining the well-defined and swelled micellar structure
(d = 59.2 ± 1.6 nm, PDI = 0.19) in diluted (0.05 mg∙mL-1) DMF solution due to the covalent
crosslinking in the micellar core. By contrast, the NCLMs become destabilized in dilute DMF
solution, as evidenced by an increase of the hydrodynamic size, broadening of the size distribution
(PDI = 0.41) and the appearance of unimers by DLS analysis (Figure 4.3 (B)). Further TEM
analysis of both dried and uranyl acetate-stained CCLMs and NCLMs revealed the presence of
mostly spherical micelles with occasionally short cylinders, suggesting that covalent crosslinking
in the micellar core did not significantly alter the micellar morphology (Figure 4.4). The average
diameter of the CCLMs (21.1 ±2.3 nm) is comparable to that of the NCLM precursors (22.8 ±2.9
nm) in the dry state.
To investigate whether the CCLMs can dissociate in reductive environment, an aqueous
solution of CCLMs was treated with DTT (10 mM) at room temperature under a nitrogen
atmosphere for 36 h. The reaction mixture was then dried under vacuum and further purified by
re-dissolution in CH2Cl2 and precipitation with an excess diethyl ether. 1H NMR analysis of the
purified polymer product in CD2Cl2 revealed the increased intensity of decyl protons of N-decyl
glycine (D) segments at 1.25 ppm relative to those of the CCLMs and the appearance of the
characteristic triazole protons at 8.0 ppm after the DTT treatment (Figure S4.2). This is consistent
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with the formation of new polymeric unimers bearing polar groups (e.g., triazole and thiol) from
the DTT-induced un-crosslinking of the CCLMs and the micellar dissociation (Scheme S4.1).
(A)

(B)

1.0

0.8

Normalized Intensity

Normalized DRI

1.0

0.6
0.4
0.2
0.0

0.8
0.6
0.4
0.2
0.0

14

16

18

20

22

24

26

28

1

Elution Volume (mL)

10

100

1000

10000

Size (d, nm)

Figure 4.3. (A) Representative SEC chromatograms of the E204Pg13D15 unimer (—) and the
corresponding CCLMs before (—) and after DTT treatment (—) in DMF/ 0.1 M LiBr. (B) DLS
size distribution of the E204Pg13D15-based NCLMs in water (- ■ -) or DMF (- ■ -) and the
corresponding CCLMs in water (-■-) or DMF (-■-). The micellar solutions in water or DMF are
kept at 0.5 mg∙mL-1 or 0.05 mg∙mL-1 respectively in the DLS studies.
(A)
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Figure 4.4. (A) TEM micrographs of the NCLMs and (B) CCLMs based on the E204Pg13D15 block
copolypeptoids. Samples were first stained with uranyl acetate prior to TEM imaging.
SEC analysis of the DTT-treated CCLMs in DMF revealed a broad bimodal peak with
significantly reduced hydrodynamic sizes relative to the CCLMs, confirming the dissociation of
the CCLMs upon DTT treatment (Figure 4.3 (A)). The peak at the higher elution volume is
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attributed to the newly formed unimers from disintegration of the CCLMs and the shoulder peak
at lower elution volume is presumably due to the unimer aggregation or incomplete micellar
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Figure 4.5. Plots of fluorescence intensity of 1,8-ANS-loaded core-crosslinked micelles (CCLMs)
or irreversibly core-crosslinked micelles (ICCLMs) composed of E204Pg13D15 in solution versus
time after the addition of varying amount of DTT (0-10 mM).
The DTT-triggered dissociation of the CCLMs was also demonstrated by monitoring the
release of encapsulated 1,8-ANS from the CCLMs in the presence of varying concentration of
DTT in the 0.045 μM-10 mM range (Figure 4.5). An aqueous solution of ANS-loaded CCLMs
was prepared and then diluted below the CMC of the non-crosslinked micellar analog (0.05
mg∙mL-1, Entry 1, Table 4.1). The fluorescence intensity of the solution at = 470 nm was
monitored at room temperature over a period of 350 min (Figure 4.5). The fluorescent intensity
was shown to decrease over time and eventually flatten out to a constant non-zero value. Increasing
the initial DTT concentration gives rise to accelerated fluorescence intensity decay and enhanced
percentage fluorescent intensity reduction, suggesting faster and more 1,8-ANS release with higher
DTT concentration in the solution. When the initial DTT concentration is 0.45 M, 1 mM and 10
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mM, the ultimate percentage reduction of the fluorescent intensity is approximately the same at
50%, indicating incomplete release of 1,8-ANS. This is tentatively attributed to the physical
association of the 1,8-ANS with the resulting unimers after DTT treatment and the corresponding
small aggregates (Figure 4. 3(A)). By contrast, 1,8-ANS-loaded CCLMs without DTT treatment
and 1,8-ANS-laoded ICCLMs treated by 10 mM DTT only exhibited a minimal reduction of the
fluorescence intensity by 5% and 2% respectively over a period of 350 min. These results clearly
indicate that CCLMs can be used to encapsulate hydrophobic molecules and release them on
demand under reductive conditions with DTT present.
To demonstrate the utility of the CCLMs for on demand drug release, we investigated the
encapsulation and release of Doxorubicin (DOX), a hydrophobic cancer drug using the corecrosslinked diblock copolypeptoid micelles. DOX-loaded CCLMs were prepared by mixing DOX
with the E204Pg13D15 and the reductively active CL1 crosslinker in the presence of CuCl2 and
sodium ascorbate in H2O and a small amount of DMF (0.5-1.5 vol.%). The reaction solution was
centrifuged to remove any precipitated DOX and then dialyzed against DI water to yield the final
DOX-loaded CCLMs. The initial DOX to polymer mass ratio (IDP) was systematically varied to
assess the effect on the drug loading capacity (DLC) and drug loading efficiency (DLE).
The drug loading capacity (DLC) is the ratio of the mass of the encapsulated drug over the
mass of the drug-loaded micelles, whereas the drug loading efficiency (DLE) is the ratio of the
mass of the encapsulated drug in the micelles over the total mass of the drug used in the
encapsulation process. We have found that core-crosslinking enhances the drug loading capacity
and drug loading efficiency, as indicated by 2.8% and 4.8% DLC and 20% and 28% DLE for the
DOX-loaded non-core-crosslinked micelles (NCLMs) and the corresponding core-crosslinked
micellar counterpart (CCLMs) (Entry 1 and 2, Table 4.2). Inspired by an early report that drug
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loading capacity can be enhanced by tuning the initial drug to polymer (IDP) ratio, 227 we
systematically varied the IDP ratio from 15:100 to 60:100 during the preparation of the DOXloaded CCLMs. It was found that the DLC of the DOX-loaded CCLMs increased from 4.8% to
20.3%. Further increase of the IDP ratio to 80:100 only enhanced the DLC by a modest percentage
(2.8%) to 23.1%. The DLE also increases from 28% to 37% as the IDP is increased from 15:100
to 80:100; the dependence of DLE on IDP is more moderate relative to that of the DLC.
Table 4.2. DLC and DLE of the NCLMs and CCLMs based on the E204Pg13D15 polymer (Entry 1,
Table 4.1) with varying IDP ratios.
Entry

Sample

IDP ratio a

DLC (%) b

DLE (%) c

1

DOX-loaded NCLMs

15:100

2.8 (±0.3)

20 (±3)

2

DOX-loaded CCLMs

15:100

4.8 (±0.2)

28 (±2)

3

DOX-loaded CCLMs

30:100

9.6 (±1.7)

30 (±3)

4

DOX-loaded CCLMs

60:100

20.3 (±1.9)

36 (±2)

5

DOX-loaded CCLMs

80:100

23.1 (±1.5)

37 (±4)

a.

The initial DOX and polymer mass ratio (IDP);
loading efficiency (DLE).

b.

drug loading capacity (DLC);

c.

drug

Investigation of the drug release profile of the DOX-loaded CCLMs was conducted in PBS
buffer with or without DTT (10 mM) present at 37°C over the course of 30 h and compared to that
of the DOX-loaded NCLMs without DTT (Figure 4.6). Specifically, the DOX-loaded CCLMs and
DOX-loaded NCLMs were dissolved in the PBS buffer and then dialyzed against the buffer
solution over time. It should be noted that the initial concentrations of DOX-loaded CCLMs and
DOX-loaded NCLMs were diluted to be lower than the CMC of the NCLMs to induce the micellar
dissociation. Aliquots of the outside buffer solution were taken, processed and analyzed by the
fluorescence excitation spectroscopy with an emission wavelength at = 560 nm after every few
hours. The DOX concentration from the aliquots was determined using a standard curve that
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correlates the fluorescence excitation intensity at = 480 nm with the DOX concentration. The
DOX-loaded CCLMs exhibited a gradual release profile with a 40 % DOX released from the
micelles over a period of 30 h after DTT addition (Figure 4.6). By contrast, less than 5 % DOX
was released over the same period of time without the DTT addition. Prolonged incubation time
up to 50 h did not result in significant further increase of the DOX release (<5%). We tentatively
attribute this to the association of the DOX with the unimers or small aggregates formed from the
dissociation of the CCLMs (Figure 4.3 (A)), thus limiting the ultimate degree of DOX release. In
comparison, the DOX-loaded NCLMs without DTT present exhibited a similar DOX release
profile to that of the CCLMs with DTT present in the first 10 h (Figure 4.6). The maximum release
of DOX (35%) from the NCLMs is slightly lower than that of the CCLMs with DTT (40%). This
is probably due to the reduced stability of the CCLMs after un-crosslinking at the core relative to
that of the NCLMs, considering that the un-crosslinked CCLMs bear more polar groups (e.g.,
triazole and thiol) in the solvophobic blocks relative to the NCLMs and thus facilitating the
dissociation of the formers (Scheme S4.1). The above results clearly indicate that the CCLMs
based on the block copolypeptoids can efficiently encapsulate hydrophobic drugs with good to
moderate DLC and DLE and the drugs can be gradually released on demand in the presence of
DTT. We caution the extrapolation of the DOX release behavior of CCLMs or NCLMs shown
here (Figure 4.6) to those with other bio-reductants (e.g., GSH) or in cellular media (vide infra),
as the rate of micellar dissociation due to cleavage of the disulfide crosslinkers may vary and the
complex cellular environment can give rise to alternative degradation pathways for CCLMs or
NCLMs.53
CCLMs and ICCLMs exhibit minimal cytotoxicity to HepG2 cells (a perpetual cell line
consisting of human liver carcinoma), supported by the cell viability study using MTT assays.
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More than 95% HepG2 cells remain alive after 48 h incubation with CCLMs or ICCLMs in the
0.01- 1 mg∙mL-1 concentration range (Figure 4.7).
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Figure 4.6. Plots of cumulative DOX release from the CCLMs (-■-) over time with the presence
of DTT ([DTT]0= 10 mM) and CCLMs (-■-) and NCLMs (-■-) without the presence of DTT.
The CCLMS and NCLMs are both comprised of the E204Pg13D15 polymer.
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Figure 4.7. Percentage HepG2 cell viability after being cultured with CCLMs and ICCLMs both
comprised of the E204Pg13D15 block copolypeptoids for 48 h and characterized by MTT assays.
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Figure 4.8. (A) The plots of percentage cell inhibition versus DOX concentration and (B) timedependent cell inhibition studies at 40 g∙mL-1 equivalent DOX concentration for the DOX-loaded
CCLMs (■), DOX-loaded ICCLMs (■) and free DOX∙HCl (■). HepG2 cells were used in the study.
The CCLMS and ICCLMs are both comprised of the E204Pg13D15 polymer.
In addition, statistical T test was conducted for each concentration, and there was no
significant difference (95% confidence interval) observed for the effect of CCLMs and ICCLMs
on the percentage cell viability (Figure 4.7). Inhibition of tumor cell growth and proliferation was
investigated by incubating DOX-loaded CCLMs, DOX-loaded ICCLMs, and free DOX∙HCl with
HepG2 cells for 48 h with varying DOX concentration (0.1 - 100 g∙mL-1). Cell inhibition is
quantitatively defined as the percentage of cell death at different conditions relative to the positive
control (i.e., cells only without any DOX). All three samples inhibited the growth and proliferation
of HepG2 cells, as supported by increasing percentage cell inhibition with increasing DOX content
in the solution (Figure 4.8 (A)). The cell inhibition by the DOX-loaded CCLMs is much lower
than that of the free DOX∙HCl in the entire DOX concentration range (0.1- 100 g∙mL-1). For
example, a 62% cell inhibition was observed for the DOX-loaded CCLM solution relative to the
82% in the free DOX∙HCl solution. The DOX-loaded ICCLMs also inhibited the HepG2 cells’
growth and proliferation but at a reduced level relative to the DOX-loaded CCLMs. This suggests
that the release of DOX from ICCLMs may occur through polymer degradation by other
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mechanisms (e.g., oxidative degradation) in the cellular environment.165 A time-dependent study
of tumor cell inhibition activity over the course of 72 h was also conducted using the three samples
at a constant DOX concentration (40 g∙mL-1) (Figure 4.8 (B)). Notable tumor cell inhibition
activities were observed with free DOX∙HCl with 40% cell death after 12 h incubation. By contrast,
DOX-loaded CCLMs and DOX-loaded ICCLMs exhibited delayed onset of tumor cell inhibition
activities, evidenced by 15% and 19% cell inhibition at 22 h and 36 h for the former and the latter,
respectively. After 72 h incubation, the DOX∙HCl, DOX-loaded CCLMs and DOX-loaded
ICCLMs exhibited a maximal cell inhibition of 84%, 64% and 49% respectively. Statistical T-tests
revealed that the DOX-loaded CCLMs and DOX-loaded ICCLMs exhibited significantly different
cell inhibition against HepG2 cells in the 5 to 100 µg·mL-1 concentration range (Figure 4.8 (A))
and over the 22 to 72 h time window (Figure 4.8 (B)) (P < 0.05). The higher tumor cell inhibition
activities of DOX-loaded CCLMs relative to the DOX-loaded ICCLMs are tentatively attributed
to the un-crosslinking of the CCLM micellar core under reductive environment in cancer cells,
thereby enabling more efficient release of DOX and resulting in more HepG2 cell death from the
CCLMs than the ICCLMs.
4.4 Conclusions
The first redox-responsive core-crosslinked micelles (CCLMs) based on amphiphilic block
copolypeptoids were synthesized by combining primary amine-initiated ring-opening
polymerization method with CuAAC click chemistry. The micellar structures (i.e., size) can be
tailored by adjusting the chemical composition of the constituting polymers. The polypeptoidbased CCLMs were shown to respond to reducing cues in solution (e.g., DTT) by disintegrating
into unimers or small aggregates. Both CCLMs and ICCLMs were minimally cytotoxic to HepG2
cells, evidenced by the cell viability study. Doxorubicin (DOX) can be efficiently encapsulated
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within the polypeptoid-based CCLMs with maximally attainable 23% drug loading capacity and
34% drug loading efficiency. Accelerated drug release from the DOX-encapsulated CCLMs can
be achieved by the addition of DTT in the micellar solution. In vivo cell culture studies revealed
that the DOX-loaded CCLMs exhibited higher tumor cell inhibition activities against HepG2 cells
than that of the DOX-loaded ICCLMs. This is attributed to the redox-triggered disintegration of
the CCLMs in the cellular environment, resulting in more efficient release of the DOX from the
CCLMs than the ICCLMs. However, the CCLMs have the drawbacks of incomplete drug release,
resulting in lower tumor cell inhibition activity than the free DOX∙HCl. This study suggests the
potential use of polypeptoid-based CCLMs as redox-responsive nanocarriers for cancer therapy.
Future efforts will focus on the new chemical designs of polypeptoid-based CCLMs (i.e.,
crosslinkers and polymer structures) to improve total drug release efficiency.
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4.5 Supplementary Data
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Figure S4.1. SEC chromatograms of PNEG-b-P(NPgG-r-NDG) with varying compositions (Entry
1-5, Table 4.1).
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Figure S4.2. (A) 1H NMR spectra of the E204Pg13D15 unimer (Entry 1, Table 4.1), (B) the
corresponding core-crosslinked micelles (CCLMs) and (C) the disintegrated micelles after DTT
treatment in CD2Cl2.
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Scheme S4.1. Synthesis of CCLMs and Cleavage of CCLMs using DTT.
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Chapter 5. Conclusions and Remarks
A big progress has been made by polymer chemists on the synthesis and characterization
of diverse and functional polypeptoids in the past decade. In the next stage, how far a polypeptoid
scientist can go in the biomedical application depends strongly on how easy and versatile the
synthetic approaches can be. Pursuing facile polymerizations of polypeptoids never ends. It is a
pleasure to work on this emerging but promising polymer in my graduate career. I could enrich
the library of facile synthetic methods towards cyclic polypeptoids and push the polypeptoids in
the biomedical research a little step further.
Amidine-mediated ring-opening polymerization (ROP) of N-butyl N-carboxyanhydrides
(Bu-NCA) was investigated from four aspects, including the control over molecular weight (Mn)
and molecular weight distribution (PDI), the identification of the polymerization, the kinetics of
the polymerization, and the investigation of the polymer architecture. It was shown by this study
that well-defined cyclic poly(N-butyl glycine)s (PNBGs) can be synthesized via this
polymerization. The bicyclic amidine, DBU, is a good alternative of N-heterocyclic carbene (NHC)
to mediate zwitterionic ring-opening polymerization (ZROP). However, the polymerization has
slow initiation, and the Mns of high molecular weight PNBGs are deviated from theoretical values.
Seeking better alternatives among other organo-catalysts (e.g. pyridines, tertiary amine, and
bicyclic guanidines) is still necessary.
By following the lately developed synthetic pathway, the cyclic bottlebrush polypeptoids
which may possess unique properties were synthesized. The cyclic bottlebrush polypeptoids adopt
a toroid structure in dry state and a cyclic architecture in methanol. In contrast, the linear
bottlebrush polypeptoid analogs form rod-like aggregates in dry state. Out of expectation,
zwitterionic cyclic polypeptoids have a strong tendency to form clusters in methanol. This
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observation was further supported by the DLS analysis and the cryo-TEM image of cyclic
bottlebrush polypeptoids (targeted DP= 400). The interplay of dipole-dipole interaction and
solvophobic interaction is the driving force for the cluster formation, which cannot be prevented
by the brush-like side chains of cyclic bottlebrush polypeptoids. This is the first time for us to
perceive the effect of dipole-dipole interaction on the aggregation behaviors of zwitterionic cyclic
polypeptoids in methanol.
The first smart drug carriers based on amphiphilic diblock copolypeptoids were
synthesized via click chemistry. Our study demonstrated that the synthesized core-crosslinked
micelles (CCLMs) are mono-disperse spherical micelles in both water and DMF. High drug
loading capacity (DLC) (up to 23.1%) can be obtained by increasing the initial drug to polymer
ratios (IDP). The CCLMs were shown to exhibit good biocompatibility and cancer cell inhibition
activity. Polypeptoid-based micelles can be further assessed in the next stage of biomedical
research. Fast cleavage of the disulfide crosslinking sites of the CCLMs upon treatment of
dithothreitol (DTT) was indicated by the study of micellar dissociation (Chapter 4, Figure 4.5), but
incomplete dissociation of and limited drug release efficiency of the CCLMs were observed. One
possible reason for the problems is that the hydrophobic poly(N-butyl glycine) (PNDG) segments
form crystallization after crosslinking, which prevents the disulfide cleavage deeper inside the
hydrophobic core. The next-generation redox-responsive CCLMs composed of polypeptoids with
the potential to undergo complete dissociation under a reducing environment can be prepared by
using hydrophobic polypeptoids without side chain crystallization (e.g. poly(N-2-ethyl-1-hexyl
glycine)).
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